cefixime has been researched along with cefotaxime in 385 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 121 (31.43) | 18.7374 |
| 1990's | 246 (63.90) | 18.2507 |
| 2000's | 11 (2.86) | 29.6817 |
| 2010's | 6 (1.56) | 24.3611 |
| 2020's | 1 (0.26) | 2.80 |
| Authors | Studies |
|---|---|
| Blickle, JF; Brogard, JM; Jehl, F; Monteil, H; Schloegel, M; Westphal, JF | 1 |
| Kumamoto, Y | 1 |
| Johnson, DM; Jones, RN | 2 |
| Hirose, T; Kumamoto, Y; Nishimura, M; Ohya, S; Shibuya, A; Tsukamoto, T | 1 |
| Andremont, A; Bourneix, C; Chachaty, E; Corthier, G; Depitre, C; Mario, N; Saulnier, P | 1 |
| Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Pfaller, MA; Washington, JA | 2 |
| Fah, YS; Powell, M; Seymour, A; Williams, JD; Yuan, M | 1 |
| Chiba, N; Hunt, RH; Rademaker, JW; Rao, BV | 1 |
| Block, SL; Hedrick, JA; Tyler, RD | 1 |
| Hattori, R; Ito, Y; Kinukawa, T; Miyake, K; Narushima, M; Obata, K; Otani, T; Sakata, T; Takita, T | 1 |
| Bingen, E; Bourgeois, F; Chardon, H; Doit, C; Lambert-Zechovsky, N | 1 |
| Bouten, A; Carbon, C; Deslandes, A; Duverne, C; Farinotti, R; Trouvin, JH; Westphal, JF | 1 |
| Bedford, KA; Holt, HA; MacGowan, AP; Reeves, DS | 1 |
| Hatakeyama, K; Hori, M; Nakano, K; Sakaguchi, N; Sugita, M; Toyonaga, Y; Yamazaki, M; Yamori, K | 1 |
| el Benna, J; Jemni, A; Labro, MT | 1 |
| Borderon, JC; Bremond, M; Despert, F; Laugier, J | 1 |
| Blickle, JF; Brogard, JM; Dorner, M; Jehl, F; Monteil, H; Westphal, JF | 1 |
| Debbia, EA; Marchese, A; Pesce, A; Saverino, D; Schito, GC | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Yokota, N | 1 |
| Agoki, E; D'Costa, LJ; Ndinya-Achola, JO; Ombette, J; Plourde, PJ; Plummer, FA; Slaney, LA; Tyndall, M | 1 |
| Honda, S; Kakehi, K; Koda, S; Okamoto, Y; Taga, A | 1 |
| Inui, K; Saito, H; Yamamoto, M | 1 |
| Dagan, R; Einhorn, M; Lang, R; Miron, D; Pomeranz, A; Raz, R; Steinberger, J; Weinstock, A; Weintraub, A; Wolach, B | 1 |
| Schwartz, RH; Wiedermann, BL | 1 |
| Amplatz, S; Benvenuti, S; Di Fede, F; Dobrilla, G; Piazzi, L | 1 |
| Holdcroft, C | 1 |
| Arguedas, AG; Stutman, HR | 1 |
| Ikeda, F; Kitada, T; Mine, Y; Yamada, T; Yokota, Y | 1 |
| D'Amico, G; Maccarrone, G; Nicoletti, G; Pellegrino, MB; Privitera, A; Privitera, O; Russo, G; Stefani, S | 1 |
| Iseki, K; Miyazaki, K; Sugawara, M | 1 |
| Iseki, K; Kondo, Y; Miyazaki, K; Shiroto, H; Sugawara, M; Uchino, J | 1 |
| Morita, M; Nakagawa, H; Suzuki, K | 1 |
| Asbach, HW | 1 |
| Berche, P; Boucot, I; Gehanno, P; Uhlrich, J | 1 |
| Marchisio, P; Principi, N | 1 |
| Wu, DH | 1 |
| Chassard, D; Frydman, A; Le Liboux, A; Le Roux, Y; Masala, F; Montay, G; Roche, G; Thebault, JJ; Uhlrich, J | 1 |
| Doyle, WJ; Pinero, BP; Rosenfeld, RM; Seroky, J; Swarts, JD | 1 |
| Carlin, SA; Johnson, CE; Marchant, CD; Shurin, PA | 1 |
| Clausen, CR; Del Beccaro, MA; Duncan, NO; Inglis, AF; Mendelman, PM; Richardson, MA; Stull, TL | 1 |
| Arione, R; Bramato, C; Di Nola, F | 1 |
| Berlinghieri, MC; Carbone, M; Casini, A; De Luca, M; Fera, MT; Focà, A; Liberto, MC; Puccio, R | 1 |
| Chaine, G; Mezzanotte, F; Oliary, J; Petitjean, O; Tod, B; Tod, M | 1 |
| Grimm, H | 1 |
| Dhib, M; Fillastre, JP; Godin, M; Hameau, B; Johannides, R; Leroy, A; Moulin, B | 1 |
| Bluestone, MD; Charles, D | 1 |
| Gómez-Lus, R | 1 |
| Brumfitt, W; Hamilton-Miller, JM | 1 |
| Ascher, DP; Cieslak, TJ; Modica-Lucero, S; Ottolini, MG | 1 |
| Chapman, PA; Jewes, L; Siddons, CA; Zadik, PM | 1 |
| Maruyama, S; Sakata, H | 1 |
| Flanagan, C; Nash, DR; Steele, LC; Wallace, RJ | 1 |
| Carlin, SA; Christopher, NC; Johnson, CE; Rehmus, JM; Roberts, DG; Shurin, PA; Super, DM; Whitwell, JK | 1 |
| Erwin, ME; Jones, RN | 1 |
| Covino, JM; Douglas, JM; Ehret, JM; Handsfield, HH; Hook, EW; McCormack, WM; Reichart, CA; Verdon, MS | 1 |
| Cates, W; Hinman, AR | 1 |
| Kim, H; Kim, WJ; Ko, KY; Oh, J | 1 |
| Lundberg, C; Piippo, T; Pitkäjärvi, T; Stefansson, S | 1 |
| Iwai, N; Nakamura, H | 1 |
| Fujimura, M; Hayashi, M; Kanaya, N; Kurashima, K; Matsuda, T; Namura, M; Ogawa, H; Oya, T | 1 |
| Iwai, N; Kasai, K; Maki, T; Matsui, Y; Nakamura, H; Ozaki, T; Taneda, Y; Tauchi, N; Yamaguchi, H | 1 |
| Berlinghieri, MC; Carbone, M; Fera, MT; Focà, A; Liberto, MC; Matera, G; Puccio, R | 1 |
| Leonhardt, L | 1 |
| Kersten, W; Müsken, H | 1 |
| Bauernfeind, A; Benner, U; Theopold, M | 1 |
| Benner, U; Blessing, R; Pelz, K; Schlenter, WW | 1 |
| Jorde, W; Schata, M | 1 |
| Naber, KG | 1 |
| Segal, A; Tröster, K; Weissbach, L | 1 |
| Backhaus, A; Tinzl, J | 1 |
| Helwig, H | 1 |
| Kees, F; Naber, KG | 1 |
| Bauernfeind, A; Jungwirth, R; Schweighart, S; Theopold, M | 1 |
| Ikeda, F; Mine, Y; Tatsuta, M; Yokota, Y | 1 |
| Kalbfleisch, JH; Roberson, D; Sarubbi, F; Verghese, A | 1 |
| Chassagne, P; Daragon, A; Deshayes, P; Le Loet, X; Lecomte, R; Mejjad, O | 1 |
| Bowie, WR; Lefebvre, K; Megran, DW; Willetts, V | 1 |
| Caravaggio, C; Leggett, NJ; Rybak, MJ | 1 |
| Iishi, H; Ishikawa, H; Okuda, S; Tatsuta, M; Yokota, Y | 1 |
| Gudipati, S; Midkiff, BR; Westblom, TU | 1 |
| Carmichael, C; Carmichael, K | 1 |
| Kanba, M; Nakagawa, T; Toyoda, Y; Yamaoka, K; Yano, Y | 1 |
| Costongs, R; Davies, BI; Maesen, FP | 1 |
| Hori, R; Inui, K; Katsura, T; Okano, T; Tomita, Y | 1 |
| Aarons, D; McCarthy, M; Scott, HV | 1 |
| Hiraoka, M; Inoue, M; Matsui, H; Mitsuhashi, S | 1 |
| Grobecker, H; Kees, F; Naber, KG; Sigl, G; Ungethüm, W | 1 |
| Fukasawa, M; Mutoh, M; Nagata, H; Nouda, H; Okuda, T; Ueda, S; Yamada, H | 1 |
| Chonmaitree, T; Howie, VM; Owen, MJ | 1 |
| Fleckenstein, G; Moorthi, K; Nies, B | 1 |
| Andrews, JM; Ashby, JP; Baldwin, DR; Honeybourne, D; Wise, R | 1 |
| Himes, SL; Mortensen, JE | 1 |
| Bechtold, H; Jähnchen, E; Nies, B; Trenk, D; Wagner, F | 1 |
| Ketelbey, JW; Pannowitz, D; Scott, HV | 1 |
| Kuhlwein, A; Nies, BA | 1 |
| Nies, BA | 1 |
| Bure, A; Chanal, M; Coulet, M; Dabernat, H; Kitzis, MD; Muller-Serieys, C; Reynaud, AE; Soussy, CJ; Thabaut, A; Vergnaud, M | 1 |
| Roche, G | 1 |
| Duval, J; Meyran, M; Soussy, CJ | 1 |
| Dabernat, H; Delmas, C | 1 |
| Boussougant, Y; Weber, P | 1 |
| Bellon, O; Chardon, H; Giraud, E; Lagier, E | 1 |
| Duval, J; Fournier, G; Jarlier, V; Legrand, P; Nicolas, MH; Philippon, A | 1 |
| Cluzel, R | 1 |
| Bouanchaud, DH; Roche, G; Rolin, O | 1 |
| Desnottes, JF; Diallo, N; Loubeyre, C | 1 |
| Barré, J | 1 |
| Frydman, A; Gaillot, J; Le Liboux, A; Montay, G; Roche, G; Thebault, JJ | 1 |
| Gaudin, C; Lebrec, D; Montay, G; Roche, G; Singlas, E; Taburet, AM | 1 |
| Couraud, L; Grellet, J; Roche, G; Saux, MC | 1 |
| Baron, S; Bégué, P; Garabédian, N; Quinet, B | 2 |
| Brion, N; Montagne, A; Nicolas, P; Petitjean, O; Tod, M | 1 |
| Hugues, FC; Le Jeunne, C | 1 |
| Modai, J | 2 |
| Bossard, B; Gehanno, P; Peynègre, R | 1 |
| Regnier, B | 1 |
| Boudignat, O; Roche, G; Zylbertrest, R | 1 |
| Carbon, C | 1 |
| Bingen, E; Lambert-Zechovsky, N | 1 |
| Chaffin, DO; Henritzy, LL; Lent, K; Mendelman, PM; Smith, AL; Stull, TL; Wiley, EA | 1 |
| Healy, DP; Racht, EM; Sahai, JV; Sterling, LP | 1 |
| Iwao, N; Kameoka, H; Miyoshi, S; Mizutani, S; Takano, Y | 1 |
| Bodor, FF | 1 |
| Beumer, HM | 1 |
| Arakawa, M; Asano, Y; Gotoh, T; Imanaka, K; Kakizaki, H; Koyanagi, T; Kubota, M; Nagamori, S; Nonomura, K; Togashi, M | 1 |
| Iwao, N; Kameoka, H; Matsuda, M; Miyoshi, S; Mizutani, S; Nakano, E; Sagawa, S; Sakurai, T; Sekii, K; Sonoda, T | 1 |
| Cox, CE | 1 |
| Brogden, RN; Campoli-Richards, DM | 1 |
| Leigh, AP; Millar, ED; Robinson, D | 1 |
| Akiyama, F; Akiyama, Y; Ito, S; Kanaoka, H; Mayumi, M; Mikawa, H; Takahashi, Y; Takeshita, S; Watanabe, Y; Yoshimura, T | 1 |
| Fujii, H; Fujisawa, M; Hashimoto, H; Inagaki, N; Miyata, M; Okamura, K; Sasaki, M; Yachiku, S; Yamaguchi, S; Yamauchi, K | 1 |
| Andrews, JM; Linong, G; Stone, JW; Wise, R | 1 |
| Castellani, P; Della Bruna, C; Rossi, R; Younes, G | 1 |
| Dorow, P | 1 |
| Hirooka, H; Nakashima, E; Tamai, I; Terasaki, T; Tsuji, A | 1 |
| Bryant, A; Iravani, A; Johnson, D; Richard, GA | 1 |
| Johnson, D; Kiani, R; Nelson, B | 1 |
| Noel, GJ; Teele, DW | 1 |
| Akita, H; Ishikawa, K; Iwata, S; Kumagai, N; Kusumoto, Y; Nanri, S; Oikawa, T; Sato, Y; Shiro, H; Yokota, T | 1 |
| Black, WA; Bowie, WR; Boyd, J; Chan, DG; Shaw, CE | 1 |
| Baugher, LK; Counts, GW; Hamilton, DJ; Ulness, BK | 1 |
| Barry, AL; Jones, RN | 2 |
| Arakawa, M; Muramatsu, Y; Ozaki, K; Satou, T; Takano, M; Tasaki, K; Wada, K | 1 |
| Bremm, KD; Knöller, J; Köller, M; König, W; Schönfeld, W | 1 |
| Hori, R; Inui, K; Kato, M; Maegawa, H; Okano, T; Takano, M | 1 |
| Bohaychuk, W; Desjardins, RE; Faulkner, RD; Haynes, JD; Silber, BM; Yacobi, A | 1 |
| Falkowski, AJ; Faulkner, RD; Fernandez, P; Lawrence, G; Sia, LL; Silber, BM; Weiss, AI; Yacobi, A | 1 |
| Fass, RJ; Helsel, VL | 1 |
| Movin, G; Nord, CE; Stålberg, D | 1 |
| Lin, SR; Peng, CF | 1 |
| Eng, RH; Smith, SM | 1 |
| Knapp, CC; Sierra-Madero, J; Washington, JA | 1 |
| Kelly, KJ; Kumar, A | 1 |
| Chin, NX; Neu, HC | 1 |
| Cullmann, W; Dick, W; Opferkuch, W; Stieglitz, M | 1 |
| Baba, S; Itoh, Y; Kawamura, S; Kinoshita, H; Kobayashi, K; Mori, Y; Onishi, S; Shimada, J; Suzuki, K; Ueda, R | 1 |
| Asai, H; Itoh, Y; Kawamura, S; Kobayashi, K; Matsunaga, T; Ogino, H; Onishi, S; Sakamoto, Y; Shiraishi, T; Ueda, R | 1 |
| Shimada, K | 1 |
| Barone, JS; Clark, PA; Risser, WL; Simpkins, DL | 1 |
| Cartwright, K; Desjardins, RE; McCarthy, EF; Tally, FP | 1 |
| McLinn, SE | 1 |
| Kin, Y; Tamai, I; Tsuji, A | 1 |
| Bohaychuk, W; Desjardins, RE; Faulkner, RD; Haynes, JD; Lanc, RA; Silber, BM; Yacobi, A | 1 |
| Bohaychuk, W; Desjardins, RE; Faulkner, RD; Haynes, JD; Look, ZM; Silber, BM; Weiss, AI | 1 |
| Falkowski, AJ; Look, ZM; Noguchi, H; Silber, BM | 1 |
| Cantekin, EI; Doyle, WJ; Hotaling, AJ | 1 |
| Mulligan, ME | 1 |
| Bergeron, MG; Boucher, FD; Lavoie, GY | 1 |
| Powell, M; Williams, JD | 1 |
| Batra, VK; Bialer, M; Look, ZM; Morrison, JA; Silber, BM; Yacobi, A | 1 |
| Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
| Nishimura, T; Tabuki, K; Takagi, M; Takashima, T | 1 |
| Brink, G; Fourie, S; Levenstein, J; Michaelides, B; Murray, E; Naidoo, N; Summerfield, PJ | 1 |
| Bergeron, MG; Turcotte, A | 1 |
| Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN | 1 |
| Bremm, KD; Knöller, J; König, W; Schönfeld, W | 1 |
| Hirooka, H; Tamai, I; Terasaki, T; Tsuji, A | 3 |
| Edelstein, MA; Finegold, SM; Gee, R; Ingram-Drake, L; MacDonald, K; Reinhardt, J; Wexler, H | 1 |
| Kobayashi, T; Koda, S; Morimoto, Y; Namiki, Y; Okimura, Y; Tanabe, J; Tanabe, T | 1 |
| Bialer, M; Look, ZM; Silber, BM; Wu, WH; Yacobi, A | 1 |
| Faulkner, RD; Hiltke, MF; McAteer, JA; Silber, BM | 1 |
| Neu, HC | 1 |
| Barone, JS; Faulkner, RD; Kaplan, SA; Silber, BM; Yacobi, A | 1 |
| Howie, VM; Owen, MJ | 1 |
| Blatter, MM; Bluestone, CD; Fall, P; Kenna, MA; Kurs-Lasky, M; Reisinger, KS; Stephenson, J; Wucher, FP | 1 |
| Arimasu, O; Fujii, R; Meguro, H; Sohda, H; Togasaki, K; Yoshida, J | 1 |
| Chikaoka, H; Kamigaki, M; Koido, R; Matsumoto, K; Nakazawa, S; Narita, A; Niino, K; Sato, H; Suzuki, H | 1 |
| Asaishi, T; Ishizuka, Y; Iwata, S; Kumagai, N; Kusano, S; Kusumoto, Y; Saito, N; Sato, Y; Sunakawa, K; Yokota, T | 1 |
| Hori, M; Joh, K; Kurosu, Y; Nakamura, H; Sugita, M; Takahashi, T; Toyonaga, Y | 1 |
| Hakamada, S; Hayakawa, F; Kuno, K; Miyachi, Y; Nakashima, S; Nakashima, T | 1 |
| Iwai, N; Katayama, M; Mizoguchi, F; Nakamura, H; Shibata, M | 1 |
| Haruta, T; Kobayashi, Y; Kuroki, S | 1 |
| Furukawa, S; Okada, T | 1 |
| Aihara, R; Kobashi, H; Nishioka, A; Ohara, K; Okamoto, T | 1 |
| Endo, S; Hosoda, T; Masuda, M; Mimoto, H; Miyao, M; Tanaka, H; Yuasa, Y | 1 |
| Araki, K; Kitamura, I; Kurashige, T; Morioka, N; Morita, H; Ogura, H | 1 |
| Kida, K; Matsuda, H; Miyazaki, M; Murase, M | 1 |
| Ishimoto, K; Koga, T; Motohiro, T; Nagayama, K; Nishiyama, T; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, S; Yamashita, F | 1 |
| Nakayama, N; Tsuji, Y; Yanagishima, M | 1 |
| Barry, AL; Fuchs, PC; Jones, RN | 1 |
| Brown, GR; Guay, DR; Harding, GK; Meatherall, RC | 1 |
| Kawabata, K; Miyai, K; Takasugi, H; Takaya, T | 1 |
| Arakawa, S; Fujii, A; Harada, M; Ishigami, J; Kamidono, S; Kawabata, G; Maeda, H; Sako, M; Umezu, K; Yamazaki, H | 1 |
| Hirose, T; Mine, Y; Nakamoto, S; Sakamoto, H | 1 |
| Brittain, DC; Hirose, T; Neu, HC; Scully, BE | 1 |
| Bialer, M; Tonelli, AP; Yacobi, A | 1 |
| Chiba, T; Kawabata, K; Masugi, T; Takasugi, H; Takaya, T; Yamanaka, H | 1 |
| Allen, S; Barry, A; Fuchs, P; McLaughlin, J; Pfaller, M; Sewell, D | 1 |
| Bennert, KW; Blades, EW; Cooper, GS; Jacobs, GH; Remler, BF; Salata, RA | 1 |
| Hashimoto, A; Iseki, K; Kobayashi, M; Miyazaki, K; Sugawara, M | 1 |
| Farid, Z; Girgis, NI; Hammad, O; Sultan, Y | 1 |
| Grise, P; Humbert, G; Leroy, A; Oser, B | 1 |
| Vartiovaara, I | 1 |
| Glickman, A; Lavy, E; Winkler, M; Ziv, G | 1 |
| Brogden, RN; Markham, A | 1 |
| Aroch, I; Glickman, A; Lavy, E; Ziv, G | 1 |
| Bennish, ML; Khan, WA; Salam, MA; Seas, C | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Choutet, P; Dellamonica, P; Durgeat, S; Joubert-Collin, M; Lejeune, JM; Lucht, F; Morgon, A; Pessey, JJ; Portier, H; Veyssier, P | 1 |
| Bost, C; Croizé, J; François, P; Wollschlager, K | 1 |
| Lieberman, D; Schlaeffer, F | 1 |
| Tomiyama, M | 1 |
| Barry, AL; Fuchs, PC | 1 |
| Celdrán Gil, JL; García Camba, L; Marcos Sánchez, F; Reinoso Cobo, D | 1 |
| Anderson, RL; McKnight, JT; Rodman, DP | 1 |
| Inoue, E; Mitsuhashi, S | 1 |
| García-Gestoso, ML; Martínez-Martínez, L; Pascual, A; Romero, J | 1 |
| Bhutta, ZA; Khan, IA; Molla, AM | 1 |
| Kafetzis, DA | 1 |
| Hamano, S; Nakanishi, M; Tamai, I; Terasaki, T; Tsuji, A | 1 |
| Klepser, ME; Nightingale, CH; Quintiliani, R | 1 |
| Doern, GV; Gerlach, EH; Hindler, J; Jones, RN; St Amand, R | 1 |
| Garcia Iglesias, MC; Perea, EJ | 1 |
| Bauernfeind, A; Cornaglia, G; Fontana, R; Ligozzi, M; Satta, G | 1 |
| Asmar, BI; Dajani, AS; Del Beccaro, MA; Mendelman, PM | 1 |
| Vogel, F | 1 |
| Dean, PC; Farquhar, DS; Gremse, DA | 1 |
| Iakovlev, VP | 1 |
| Leshem, Y; Raz, R; Rottensterich, E; Tabenkin, H | 1 |
| Bakst, CM; Loughlin, KA; Rybak, MJ | 1 |
| Parent, M | 1 |
| Hashimoto, A; Iseki, K; Kobayashi, M; Miyazaki, K; Sugawara, M; Takahashi, M; Toda, T | 1 |
| Rodriguez, WJ; Wiedermann, BL | 1 |
| Brown, EM; MacGowan, AP; Reeves, DS; White, LO | 1 |
| Gales, BJ; Gales, MA | 1 |
| Baquero, F; Loza, E; Morosini, MI; Negri, MC | 1 |
| Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Marshall, SA; Murray, PR; Washington, JA | 1 |
| Livermore, DM; Yeo, SF | 1 |
| Dantzig, AH; Duckworth, DC; Tabas, LB | 1 |
| Darenkov, AF; Feshchenko, IuI; Gusel', VA; Nedostup, AV; Ovchinnikov, IuM; Pluzhnikov, MS; Sereda, EV; Trofimov, VI; Ustinovich, AK; Zubovich, VK | 1 |
| Dolitsky, JN; Doyle, WJ; Magit, AE; Rosenfeld, RM; Seroky, JT; Swarts, JD | 1 |
| Bass, JW; Chan, DS; Demers, DM | 1 |
| Adloff, M; Brogard, JM; Jehl, F; Westphal, JF | 1 |
| Chick, TW; Neu, HC | 1 |
| Farid, Z; Girgis, NI; Kilpatrick, ME; Podgore, JK; Sultan, Y | 1 |
| Amir, J; Ashkenazi, S; Garty, BZ; Nitzan, M; Rachmel, A; Samra, Z; Varsano, I; Waisman, Y | 1 |
| Inamoto, Y; Kawabata, K; Sakane, K; Takaya, T; Yamanaka, H | 1 |
| Friedland, IR | 1 |
| Girbig, F; Gutjahr, U; Kowalewski, S; Kramer, W | 1 |
| Huovinen, P; Lehtonen, L | 1 |
| Andremont, A; Bonnay, M; Bourneix, C; Chachaty, E; Renard, S | 1 |
| Brogard, JM; Jehl, F; Monteil, H; Schloegel, M; Westphal, JF | 1 |
| Gao, S; Liu, GL; Sha, RG; Shen, YX; Wang, SX | 1 |
| Hefelfinger, DC | 1 |
| Berman, S; Roark, R | 1 |
| Chartrand, SA; Harrison, CJ; Pichichero, ME | 1 |
| Akram, S; Bell, TA; Chhabra, OP; Khan, W; Kohlbrenner, VM; Rodriguez, WJ; Sait, T | 1 |
| Bluestone, CD | 1 |
| Anwar, R; Bannister, ER; Howie, VM; Nguyen, HK; Owen, MJ; Swank, PR | 1 |
| Avner, SE; Bierman, WC; Chow, JM; Duerksen, RL; Edelstein, DR; Johnson, J; Kohlbrenner, VM; Matthews, BL; Ronis, M; Rybak, LP | 1 |
| Barson, WJ; Kohlbrenner, VM; Nahata, MC | 1 |
| Edelstein, DR; Kimmelman, CP; Kohlbrenner, VM; Kohut, RI; Marinaccio, AT; Matthews, BL; McCaffrey, TV; Parnes, SM; Rapp, M; Rybak, LP | 1 |
| Doyle, WJ; Greene, I; Rosenfeld, RM; Seroky, J; Swarts, JD | 1 |
| Long, SS | 1 |
| Lovering, AM; MacGowan, AP; Reeves, DS; White, LO | 1 |
| Kumano, K; Kuroyama, M; Motohashi, S; Murase, S; Tomonaga, F | 1 |
| Hausen, T; Schmitt, J; Weidlich, G | 1 |
| Bégué, P; Boulesteix, J; Dabernat, H; de La Rocque, F; Dubreuil, C; Geslin, P; Mégraud, F; Trinh, A | 1 |
| Adam, D; Hostalek, U; Tröster, K | 1 |
| Low, DE | 1 |
| Benmessaoud, K; Nouvet, G | 1 |
| Davies, HD; Fletcher, A; Goldbach, M; Ipp, M; Lloyd, D; Low, DE; O'Rourke, K; Saunders, NR; Schwartz, B; Scriver, S | 1 |
| Liston, TE | 1 |
| Beghi, GF; Casalini, A; Cazzola, M; Consigli, GF; Fiorentini, F; Giura, R; Madonini, V; Paizis, G; Tonna, M; Vinciguerra, A | 1 |
| Biro, FM; Friedland, LR; Kulick, RM; Patterson, A | 1 |
| Chapman, PA; Siddons, CA | 1 |
| Farid, Z; Girgis, NI; Sultan, Y; Tribble, DR | 1 |
| Cassetta, MI; Conti, S; Dei, R; Fallani, S; Mazzei, T; Novelli, A | 1 |
| Blandino, G; Nicoletti, G; Speciale, A | 1 |
| Garmendia, JF; Joral, A; Vilas Martínez, F; Villarreal, O | 1 |
| Boyter, A; Davey, P; Fegan, PG; Nathwani, D | 1 |
| Lee, YS; Park, H | 1 |
| Dancy, RM; Day, SW; Harris, SC; Wang, WC; Wilimas, JA; Williams, LL | 1 |
| Cappelletty, DM; Rybak, MJ | 1 |
| Dan, M; Hafeli, H; Heifetz, L; Poch, F; Somekh, E; Tanai, A | 1 |
| Mann, RD; Pearce, GL; Wilton, LV | 1 |
| Kohl, PK; Kratofiel, M; Petzoldt, D; Tu, Y | 1 |
| Kasteridou, N; Mamzoridi, K; Niopas, I; Peonides, A | 1 |
| Itokazu, GS; Karavokiros, KT; Schatz, BS; Taeubel, MA | 1 |
| Debbia, EA; Pesce, A; Schito, GC | 1 |
| Amir, J; Eidlitz-Markus, T; Harel, L; Varsano, I | 1 |
| Gooch, WM; Philips, A; Rhoades, R; Rosenberg, R; Schaten, R; Starobin, S | 1 |
| Nakagawa, T; Yamaoka, K; Yasui, H | 1 |
| Carbon, C; Farinotti, R; Harcouët, L; Lebrec, D; Rozé, C | 1 |
| Carenfelt, C; Hemlin, C; Papatziamos, G | 1 |
| Ohsawa, R; Okazaki, N; Sata, S; Suzuki, R; Wada, A; Watanabe, H; Watanabe, Y; Yamai, S | 1 |
| de Bruine, AP; Peters, FP; Stockbrügger, RW; Wouters, RS | 1 |
| Gorby, GL; Phanucharas, JP | 1 |
| Brookes, S; Coast, J; Howe, RW; Millar, MR; Peters, TJ; Whitfield, M | 1 |
| Goldstein, FW | 1 |
| Bean, K; Hook, EW; Jones, RB; Maroli, AN; Martin, D; McCormack, WM | 1 |
| Block, SL; Chartrand, SA; Harrison, CJ; Hedrick, JA; Pollack, J; Rodriguez, W; Schwartz, R; Thedinger, B | 1 |
| Johnston, M; MacRae, M; Ogden, ID; Rebate, T | 1 |
| Bajaksouzian, S; Jacobs, MR | 1 |
| Ghaffarzadeh, K; Rastegar Lari, A; Shamshiri, AR; Validi, N | 1 |
| Billoo, AG; Memon, HI; Memon, IA | 1 |
| Bhutta, ZA; Hussain, R; Mansoorali, N | 1 |
| Bégué, P; Boulesteix, J; Dabernat, H; de La Roque, F; Dubreuil, C; Geslin, P; Megraud, F; Scheimberg, A; Trinh, A | 1 |
| Jabbar, A; Siddique, T | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Fachinelli, H; Kijanczuk, S; Mingrone, H; Salvarezza, CR | 1 |
| Bektaşlar, D; Ertuğrul, A; Helvaci, M; Ozkaya, B; Umurtak, B; Yaprak, I | 1 |
| Asherov, J; Atzmon, Y; Dan, M; Edelman, A; Hafely, H; Poch, F | 1 |
| Asvanich, K; Fugpholngam, V; Srimuang, S; Tanphaichitra, D | 1 |
| Aleksic, S; Bockemühl, J; Lehmacher, A; Meier, H | 1 |
| Berkley, S; Brookmeyer, R; Gray, RH; Kelly, R; Kiwanuka, N; Li, C; Lutalo, T; McNairn, D; Nalugoda, F; Paxton, L; Quinn, TC; Serwadda, D; Sewankambo, NK; Wabwire-Mangen, F; Wawer, MJ | 1 |
| Kessler, A; Nagar, H; Weiss, J | 1 |
| Iqbal, I; Malik, MS; Rabbani, W | 1 |
| Adam, D | 1 |
| Matsumoto, Y | 1 |
| Lorenz, J | 1 |
| de Lalla, F | 1 |
| Hamilton-Miller, J | 1 |
| García-Rodríguez, JA | 1 |
| Ludwig, E | 1 |
| Iqbal, I; Malik, MS; Rabbani, MW | 1 |
| Greenman, J; Hassan, IJ; Millar, MR; Stark, RM | 1 |
| Almela, M; García San Miguel, J; Marco, F; Martínez, JA; Mensa, J; Moreno-Martínez, A; Soriano, E; Vila, J | 1 |
| Nikoskelainen, J; Oksi, J; Viljanen, MK | 1 |
| Agbaba, D; Eric-Jovanovic, S; Vladimirov, S; Zivanov-Stakic, D | 1 |
| Basly, I; Basly, JP; Bernard, M | 1 |
| Cao, XT; Kneen, R; Nguyen, TA; Parry, CM; Truong, DL; White, NJ | 1 |
| Arcidiacono, MM; Demartini, G; Dugnani, S; Fraschini, F; Pintucci, JP; Scaglione, F | 1 |
| Baskin, M; Charron, M; Hickey, RW; Hoberman, A; Janosky, JE; Kearney, DH; Majd, M; Reynolds, EA; Ruley, J; Wald, ER | 1 |
| Hao, F; Li, J; Zhao, C | 1 |
| Kamath, R | 1 |
| Chiu, CH; Lin, TY; Ou, JT | 1 |
| Enrique, E; Gaig, P; García-Ortega, P; San Miguel, MM | 1 |
| Burke, JF; Gaughan, WJ; Hassan, MH; McCue, PA; Sharma, K | 1 |
| Al-Eidan, FA; Jenkins, J; Kearney, MP; McElnay, JC; Scott, MG; Troughton, KE | 1 |
| Newton, W; Reed, K | 1 |
| Alaghehbandan, R; Lari, AR; Masjedian, F; Mostafavi, H; Noorbakhsh, S | 1 |
| Carcía-Rodriguez, JA; García-Garcia, MI; García-Sanchez, E; García-Sanchez, JE; Munõz-Bellido, JL; Trujillano, I | 1 |
| Campos, J; Cercenado, E; de Abajo, F; García-Cobos, S; García-Rey, C; Lázaro, E; Oteo, J; Pérez-Vázquez, M; Román, F | 1 |
| Tapsall, JW | 1 |
| Beksaç, MS; Katlan, D; Kir, S; Nemutlu, E | 1 |
| Franz, C; Gerber, A; Mainz, JG | 1 |
| Ajmal, M; Alqahtani, F; Aziz, M; Imran, I; Majeed, A; Rasool, MF; Rehman, AU; Saeed, H; Zamir, A | 1 |
| Brandsch, M; Luckner, P | 1 |
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Arakawa, Y; Kimura, K; Nagano, N; Nagano, Y; Tamai, K; Yanagisawa, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Chatre, P; Delmas, JM; Faure, S; Laurentie, M; Perrin-Guyomard, A | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campos, J; Carrilero, L; Escudero, JA; Garcia-Cobos, S; Gonzalez-Zorn, B; Gutierrez, B; Hidalgo, L; San Millan, A | 1 |
| Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
28 review(s) available for cefixime and cefotaxime
| Article | Year |
|---|---|
Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Cefixime; Cefotaxime; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Research Design; Sensitivity and Specificity | 1992 |
Helicobacter pylori and gastric ulcer therapy: reflections and uncertainties.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Cefixime; Cefotaxime; Cimetidine; Drug Therapy, Combination; Furazolidone; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Stomach Ulcer | 1992 |
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
[Cefixime. Microbiologic, kinetic and clinical profile].
Topics: Animals; Bacteria; Cefixime; Cefotaxime; Gonorrhea; Humans; Microbial Sensitivity Tests; Otitis Media; Pharyngitis; Respiratory Tract Infections; Tonsillitis; Urinary Tract Infections | 1991 |
[Cefixime in urinary tract infections. (Specific studies and literature review)].
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Enterobacteriaceae Infections; Humans; Urinary Tract Infections | 1990 |
Cefixime.
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Humans | 1990 |
[In vitro effect of cefixime against 200 strains of Branhamella catarrhalis. Comparison with cefotaxime].
Topics: Amoxicillin; beta-Lactamases; Cefixime; Cefotaxime; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic | 1989 |
[Pulmonary diffusion of cefixime in man].
Topics: Cefixime; Cefotaxime; Cephalosporins; Female; Humans; Lung; Lung Neoplasms; Male; Premedication | 1989 |
Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.
Topics: Anti-Infective Agents; Bacterial Infections; Cefixime; Cefotaxime; Humans | 1989 |
Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections.
Topics: Amoxicillin; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Random Allocation; Respiratory Tract Infections | 1988 |
[New antimicrobial agent series XXIII: Cefixime].
Topics: Cefixime; Cefotaxime; Humans | 1987 |
Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections.
Topics: Anti-Bacterial Agents; Bacteria; Cefixime; Cefotaxime; Clinical Trials as Topic; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections | 1995 |
A critical review of the new oral cephalosporins. Considerations and place in therapy.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Humans | 1994 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Treatment of uncomplicated infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Chlamydia Infections; Chlamydia trachomatis; Female; Gonorrhea; Humans; Male; Research Design; Sexually Transmitted Diseases, Bacterial | 1994 |
[Cefixime-- a new cephalosporin antibiotic for oral administration].
Topics: Administration, Oral; Cefixime; Cefotaxime; Humans; Molecular Structure | 1994 |
Oral treatment of gonorrhea and chlamydia.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Chlamydia Infections; Ciprofloxacin; Doxycycline; Female; Gonorrhea; Guidelines as Topic; Humans; Male; Ofloxacin; Randomized Controlled Trials as Topic | 1994 |
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans | 1994 |
[Research and development of new oral cephems, cefixime and cefdinir].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Structure-Activity Relationship | 1993 |
Cefixime therapy for otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Infective Agents; Cefixime; Cefotaxime; Humans; Otitis Media with Effusion; Pneumococcal Infections; Treatment Failure | 1993 |
Review of cefixime in the treatment of otitis media in infants and children.
Topics: Animals; Anti-Bacterial Agents; Cefixime; Cefotaxime; Child; Child, Preschool; Clinical Trials as Topic; Disease Models, Animal; Humans; In Vitro Techniques; Infant; Otitis Media | 1993 |
Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Capsules; Cefixime; Cefotaxime; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Remission Induction; Sinusitis; Time Factors | 1993 |
Cefixime.
Topics: Bacteria; Bacterial Infections; Biological Availability; Cefixime; Cefotaxime; Child; Humans; Microbial Sensitivity Tests | 1993 |
Management of otitis media. A review.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Child; Humans; Otitis Media; Penicillins; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
Gonorrhoea: single-dose oral treatment.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Gonorrhea; Humans; Penicillinase | 1996 |
Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
Topics: Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Prodrugs; Randomized Controlled Trials as Topic | 1996 |
Clinical pharmacokinetics of cefixime: a systematic review.
Topics: Anti-Bacterial Agents; Biological Availability; Cefixime; Cefotaxime; Cephalosporins; Humans | 2023 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
115 trial(s) available for cefixime and cefotaxime
| Article | Year |
|---|---|
Single-dose treatment of female acute uncomplicated cystitis.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Clinical Protocols; Colony Count, Microbial; Cystitis; Fluoroquinolones; Ofloxacin; Quinolones; Recurrence; Treatment Outcome; Urine | 1992 |
Presence of Clostridium difficile and antibiotic and beta-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Ceftizoxime; Chromosomes, Bacterial; Clostridioides difficile; DNA, Bacterial; Enterotoxins; Feces; Humans; Prodrugs; Restriction Mapping | 1992 |
Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents.
Topics: Adolescent; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Male; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1992 |
[Clinical evaluation of usefulness of cefixime (200 mg administered once daily) in the treatment of acute uncomplicated cystitis].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Cefixime; Cefotaxime; Cystitis; Drug Administration Schedule; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Middle Aged | 1992 |
[Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1992 |
Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftriaxone; Drug Evaluation; Female; Gonorrhea; Humans; Injections, Intramuscular; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Urethritis; Uterine Cervicitis | 1992 |
Once daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for treatment of urinary tract infection in infants and children.
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Male; Prospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1992 |
Helicobacter pylori and gastric ulcer therapy: reflections and uncertainties.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Cefixime; Cefotaxime; Cimetidine; Drug Therapy, Combination; Furazolidone; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Stomach Ulcer | 1992 |
Cefixime offers effective oral therapy for gonorrhea.
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Ceftriaxone; Female; Gonorrhea; Humans; Male | 1992 |
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
Single dose oral administration of cefixime 400mg in the treatment of acute uncomplicated cystitis and gonorrhoea.
Topics: Acute Disease; Administration, Oral; Cefixime; Cefotaxime; Cystitis; Double-Blind Method; Female; Gonorrhea; Humans; Male; Urethritis | 1991 |
Clinical efficacy and tolerability of cefixime in the treatment of acute sinusitis.
Topics: Acute Disease; Adult; Aged; Cefixime; Cefotaxime; Drug Tolerance; Female; Humans; Male; Middle Aged; Sinusitis | 1991 |
Cefixime vs amoxicillin in the treatment of acute otitis media in infants and children.
Topics: Acute Disease; Amoxicillin; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Otitis Media | 1991 |
Efficacy and tolerability of cefixime in otitis media. A multicentre study in over 25,000 children.
Topics: Acute Disease; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Tolerance; Female; Humans; Infant; Infant, Newborn; Male; Otitis Media | 1991 |
Comparative bioavailability study of cefixime administered as tablets or aqueous solution.
Topics: Adult; Biological Availability; Cefixime; Cefotaxime; Chromatography, High Pressure Liquid; Humans; Male; Solutions; Tablets | 1991 |
Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon".
Topics: Acute Disease; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Combinations; Efficiency; Enzyme Inhibitors; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Otitis Media; Punctures; Streptococcus pneumoniae; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Tympanic Membrane | 1992 |
Bacteriology of acute otitis media: a new perspective.
Topics: Acute Disease; Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Bacteriological Techniques; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Moraxella catarrhalis; Otitis Media; Prodrugs; Punctures; Recurrence; Single-Blind Method; Streptococcus pneumoniae; Tympanic Membrane | 1992 |
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus agalactiae | 1991 |
Cefixime compared with amoxicillin for treatment of acute otitis media.
Topics: Acute Disease; Adolescent; Amoxicillin; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Otitis Media; Streptococcus pneumoniae | 1991 |
A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group.
Topics: Administration, Oral; Adolescent; Adult; Cefixime; Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; Drug Tolerance; Female; Gonorrhea; Humans; Injections, Intramuscular; Male | 1991 |
Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children.
Topics: Acute Disease; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Child; Child, Preschool; Diarrhea; Double-Blind Method; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Otitis Media with Effusion; Streptococcus pneumoniae | 1991 |
[Treatment results using cefixime for bacterial respiratory tract infections].
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cefixime; Cefotaxime; Female; Humans; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections | 1990 |
[Clinical experiences with cefixime in the treatment of bacterial infections of the lower respiratory tract].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Bronchopneumonia; Cefixime; Cefotaxime; Citrobacter; Drug Resistance, Microbial; Drug Tolerance; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Haemophilus Infections; Humans; Male; Middle Aged; Pneumonia; Pneumonia, Pneumococcal; Prospective Studies; Proteus Infections | 1990 |
[Effectiveness and tolerance of cefixime in bacterial infections in the ENT area].
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Cefixime; Cefotaxime; Drug Tolerance; Female; Humans; Male; Otitis Media; Respiratory Tract Infections | 1990 |
[Cefixime treatment in different bacterial infections in the ENT region].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Cefixime; Cefotaxime; Drug Tolerance; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Otitis Media; Sinusitis; Tonsillitis | 1990 |
[Effectiveness and tolerance of cefixime in the treatment of acute pyelonephritis].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Body Temperature; Cefixime; Cefotaxime; Drug Tolerance; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Leukocyte Count; Male; Middle Aged; Prospective Studies; Proteus Infections; Pyelonephritis; Recurrence; Staphylococcal Infections | 1990 |
Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Bronchitis; Cefixime; Cefotaxime; Cephalexin; Chronic Disease; Gram-Negative Bacteria; Haemophilus Infections; Haemophilus influenzae; Humans; Moraxella catarrhalis; Pneumococcal Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1990 |
Single-dose oral cefixime versus amoxicillin plus probenecid for the treatment of uncomplicated gonorrhea in men.
Topics: Adolescent; Adult; Amoxicillin; Cefixime; Cefotaxime; Gonorrhea; Humans; Male; Probenecid; Randomized Controlled Trials as Topic; Urethritis | 1990 |
Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime.
Topics: Cefixime; Cefotaxime; Cimetidine; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Recurrence; Stomach Ulcer | 1990 |
Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media with Effusion; Prospective Studies; Random Allocation; Virus Diseases | 1990 |
Cefixime: clinical trial against otitis media and tonsillitis.
Topics: Administration, Oral; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Humans; Infant; Multicenter Studies as Topic; Otitis Media; Tonsillitis | 1990 |
[In vitro antibacterial effect of a new oral cephalosporin, cefixime. Results of a multicenter study].
Topics: Cefixime; Cefotaxime; Enterobacteriaceae; Immunodiffusion; Microbial Sensitivity Tests; Multicenter Studies as Topic | 1989 |
[Cefixime, the first oral third-generation cephalosporin].
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Double-Blind Method; Gram-Negative Bacteria; Humans; Prodrugs; Random Allocation | 1989 |
[In vitro effect of cefixime against 200 strains of Branhamella catarrhalis. Comparison with cefotaxime].
Topics: Amoxicillin; beta-Lactamases; Cefixime; Cefotaxime; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic | 1989 |
[Pharmacokinetic interaction of cefixime and 2 antacids. Preliminary results].
Topics: Adult; Antacids; Cefixime; Cefotaxime; Drug Interactions; Humans; Male | 1989 |
[Controlled multicentric study comparing cefixime and amoxicillin in the treatment of lower respiratory tract infections in adults].
Topics: Adolescent; Adult; Aged; Amoxicillin; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation; Respiratory Tract Infections | 1989 |
[Efficacy and tolerability of cefixime in lower respiratory tract infections in adults. French multicentric study].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Cefixime; Cefotaxime; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Respiratory Tract Infections | 1989 |
[Efficacy and tolerability of cefixime in the treatment of otorhinolaryngeal infections in adults].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefixime; Cefotaxime; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Otitis Media; Otorhinolaryngologic Diseases; Sinusitis | 1989 |
[Efficacy and tolerability of cefixime in urinary tract infections in adults. A French multicentric study].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefixime; Cefotaxime; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Urinary Tract Infections | 1989 |
[Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections].
Topics: Administration, Oral; Cefixime; Cefotaxime; Ceftriaxone; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Random Allocation; Urinary Tract Infections | 1989 |
[Comparative study of 2 dosage regimens of cefixime in the treatment of otorhinolaryngeal or bronchial infections].
Topics: Adult; Bronchial Diseases; Cefixime; Cefotaxime; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Male; Multicenter Studies as Topic; Otorhinolaryngologic Diseases | 1989 |
[Efficacy and tolerability of cefixime in international and French studies].
Topics: Cefixime; Cefotaxime; Clinical Trials as Topic; Gastrointestinal Diseases; Humans; Multicenter Studies as Topic; Otorhinolaryngologic Diseases; Respiratory Tract Infections; Urinary Tract Infections | 1989 |
Influence of an antacid containing aluminum and magnesium on the pharmacokinetics of cefixime.
Topics: Adult; Aluminum Hydroxide; Antacids; Biological Availability; Cefixime; Cefotaxime; Drug Combinations; Drug Interactions; Half-Life; Humans; Magnesium; Magnesium Hydroxide; Male | 1989 |
Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
Topics: Adult; Amoxicillin; Bacterial Infections; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections | 1989 |
Cefixime--a new oral cephalospalosin.
Topics: Adult; Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Clinical Trials as Topic; Humans | 1989 |
[Clinical evaluation of cefixime in the treatment of acute uncomplicated cystitis].
Topics: Acute Disease; Bacterial Infections; Cefixime; Cefotaxime; Clinical Trials as Topic; Cystitis; Female; Humans; Multicenter Studies as Topic | 1989 |
[Clinical evaluation of cefixime (CFIX) in the treatment of urinary tract infection].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cefixime; Cefotaxime; Child; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Urinary Tract Infections | 1989 |
Cefixime versus trimethoprim/sulfamethoxazole in treatment of patients with acute, uncomplicated lower urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Drug Administration Schedule; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Randomized Controlled Trials as Topic; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1989 |
A general practice comparative study of a new third-generation oral cephalosporin, cefixime, with amoxycillin in the treatment of acute paediatric otitis media.
Topics: Acute Disease; Adolescent; Amoxicillin; Cefixime; Cefotaxime; Child; Child, Preschool; Family Practice; Female; Humans; Infant; Male; Multicenter Studies as Topic; Otitis Media; Random Allocation | 1989 |
[Clinical studies on cefixime in pediatrics].
Topics: Adolescent; Bacterial Infections; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Multicenter Studies as Topic; Pneumonia; Respiratory Tract Infections; Urinary Tract Infections | 1989 |
Safety and efficacy of cefixime versus cefaclor in respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1989 |
A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Random Allocation; Urinary Tract Infections | 1988 |
Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections.
Topics: Amoxicillin; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Random Allocation; Respiratory Tract Infections | 1988 |
[A parallel comparative double blind study of cefixime with cefaclor in the treatment of acute suppurative otitis media in children].
Topics: Acute Disease; Age Factors; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Humans; Infant; Otitis Media; Otitis Media, Suppurative | 1987 |
[A parallel comparative double blind study of cefixime with cefroxadine in the treatment of acute lacunar tonsillitis].
Topics: Acute Disease; Cefixime; Cefotaxime; Cephalosporins; Cephradine; Clinical Trials as Topic; Double-Blind Method; Humans; Tonsillitis | 1987 |
Noncomparative, open label, multicenter trial of cefixime for treatment of bacterial pharyngitis, cystitis and pneumonia in pediatric patients.
Topics: Adolescent; Cefixime; Cefotaxime; Child; Child, Preschool; Clinical Trials as Topic; Cystitis; Diarrhea; Female; Humans; Infant; Male; Pharyngitis; Pneumonia | 1987 |
Safety profile of cefixime.
Topics: Adult; Cefixime; Cefotaxime; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Drug Administration Schedule; Drug Hypersensitivity; Feces; Female; Humans; Infant; Male; Respiratory Tract Infections; Urinary Tract Infections | 1987 |
Randomized, open label, multicenter trial of cefixime compared with amoxicillin for treatment of acute otitis media with effusion.
Topics: Acute Disease; Amoxicillin; Cefixime; Cefotaxime; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Infant; Male; Otitis Media with Effusion; Random Allocation | 1987 |
Comparison of cefixime and co-trimoxazole in acute uncomplicated urinary tract infection. A double-blind general practice study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Escherichia coli; Female; Humans; Male; Middle Aged; Proteus mirabilis; Random Allocation; Staphylococcus aureus; Staphylococcus epidermidis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1986 |
Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children.
Topics: Acute Disease; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Child; Child, Preschool; Female; Humans; Infant; Male; Otitis Media with Effusion; Patient Compliance | 1987 |
Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Resistance, Multiple; Egypt; Female; Humans; Male; Monobactams; Salmonella typhi; Treatment Outcome; Typhoid Fever | 1995 |
Cefixime penetration in human renal parenchyma.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Cefixime; Cefotaxime; Chromatography, High Pressure Liquid; Diffusion; Humans; Kidney; Kidney Cortex; Kidney Medulla; Middle Aged; Nephrectomy | 1995 |
Clinical pharmacology of cefixime in unweaned calves.
Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Bacterial Agents; Biological Availability; Cattle; Cefixime; Cefotaxime; Dosage Forms; Escherichia coli; Female; Half-Life; Injections, Intravenous; Male; Metabolic Clearance Rate; Pasteurella; Reference Standards; Salmonella | 1995 |
Treatment of shigellosis: IV. Cefixime is ineffective in shigellosis in adults.
Topics: Adolescent; Adult; Amdinocillin Pivoxil; Anti-Bacterial Agents; Cefixime; Cefotaxime; Double-Blind Method; Dysentery, Bacillary; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Shigella; Treatment Failure | 1995 |
[Efficacy and tolerance of cefotiam hexetil in the super-infected chronic sinusitis. A randomized, double-blind study in comparison with cefixime].
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Cefotiam; Chronic Disease; Double-Blind Method; Female; Humans; Male; Prodrugs; Prospective Studies; Sinusitis | 1994 |
[Comparative study of cefixime versus amoxicillin-clavulanic acid combination in the oral treatment of urinary tract infections in children].
Topics: Administration, Oral; Adolescent; Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Child; Child, Preschool; Clavulanic Acids; Drug Combinations; Drug Tolerance; Female; Humans; Infant; Male; Prospective Studies; Urinary Tract Infections | 1995 |
[The effect of cefaclor and cefixime on nasopharyngeal pathogens in children].
Topics: Acute Disease; Anti-Bacterial Agents; Bacteria; Cefaclor; Cefixime; Cefotaxime; Child; Child, Preschool; Chronic Disease; Female; Humans; Male; Nasopharynx; Otitis Media; Sinusitis | 1995 |
Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftriaxone; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Infant; Injections, Intravenous; Male; Salmonella typhi; Typhoid Fever | 1994 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.
Topics: Acute Disease; Adolescent; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Ceftizoxime; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media, Suppurative; Prodrugs; Statistics as Topic; Treatment Outcome | 1994 |
[Treatment of lower respiratory tract infections including pneumonia. Comparative study with i.vl cefotaxime/oral cefixime versus parenteral cefotaxime].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cefixime; Cefotaxime; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections | 1994 |
Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cefixime; Cefotaxime; Double-Blind Method; Female; Humans; Middle Aged; Ofloxacin; Urinary Tract Infections | 1994 |
[Clinical efficacy of cefixime (results of multicenter trials)].
Topics: Adolescent; Adult; Anti-Infective Agents; Cefixime; Cefotaxime; Child; Child, Preschool; Humans; Infant; Inflammation; Otorhinolaryngologic Diseases; Respiratory Tract Infections; Urinary Tract Infections | 1993 |
Antimicrobial drug suspensions: a blinded comparison of taste of twelve common pediatric drugs including cefixime, cefpodoxime, cefprozil and loracarbef.
Topics: Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Single-Blind Method; Smell; Suspensions; Taste | 1994 |
Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
Topics: Adult; Aged; Ambulatory Care; Analysis of Variance; Anti-Bacterial Agents; Bacteria; Cefixime; Cefotaxime; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; United States | 1993 |
A randomized, double-blind study comparing cefixime and trimethoprim-sulfamethoxazole in the treatment of childhood shigellosis.
Topics: Adolescent; Cefixime; Cefotaxime; Child; Child, Preschool; Diarrhea, Infantile; Double-Blind Method; Dysentery, Bacillary; Female; Humans; Infant; Male; Prospective Studies; Shigella; Shigella boydii; Shigella flexneri; Shigella sonnei; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Factors influencing outcome in children treated with antibiotics for acute otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media; Regression Analysis; Risk Factors; Treatment Outcome | 1993 |
Microbiologic and clinical aspects of a trial of once daily cefixime compared with twice daily cefaclor for treatment of acute otitis media in infants and children.
Topics: Acute Disease; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Female; Humans; Infant; Male; Otitis Media with Effusion | 1993 |
Cefixime vs. cefaclor in the treatment of acute otitis media in children: a randomized, comparative study.
Topics: Acute Disease; Cefaclor; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Male; Otitis Media with Effusion; Prospective Studies; Single-Blind Method | 1993 |
Efficacy of cefixime in the treatment of acute otitis media in children.
Topics: Acute Disease; Administration, Oral; Amoxicillin; Anti-Infective Agents; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Hospitals, University; Humans; Infant; Male; Otitis Media; Outpatient Clinics, Hospital; Patient Compliance; Texas; Treatment Outcome | 1993 |
Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Capsules; Cefixime; Cefotaxime; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Remission Induction; Sinusitis; Time Factors | 1993 |
Evaluation of cefixime in the treatment of bacterial maxillary sinusitis.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Cefixime; Cefotaxime; Chronic Disease; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Incidence; Male; Maxillary Sinusitis; Microbial Sensitivity Tests; Middle Aged; Outpatient Clinics, Hospital; Patient Dropouts; Radiography; Recurrence; Suction; Treatment Outcome | 1993 |
Acute otitis media in children: a study of nasopharyngeal carriage of potential pathogens and therapeutic efficacy of cefixime and amoxicillin-clavulanate.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Nasopharynx; Otitis Media | 1995 |
5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group.
Topics: Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Penicillin V; Penicillins; Pharyngitis; Streptococcal Infections; Tonsillitis | 1995 |
Comparative study of efficacy and safety of ciprofloxacin and cefixime in the treatment of acute exacerbations of chronic bronchitis after first-line treatment failure. French Study Group.
Topics: Aged; Anti-Infective Agents; Bronchitis; Cefixime; Cefotaxime; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Male | 1995 |
Evaluation of short-course therapy with cefixime or rifampin for eradication of pharyngeally carried group A streptococci. The Ontario GAS Study Group.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cefotaxime; Child; Drug Administration Schedule; Humans; Pharyngitis; Rifampin; Streptococcal Infections; Streptococcus pyogenes | 1995 |
Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis; Cefixime; Cefotaxime; Chronic Disease; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 1995 |
Betalactam therapy and intestinal flora.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria, Anaerobic; Bronchitis; Cefixime; Cefotaxime; Ceftizoxime; Cefuroxime; Cephalosporins; Chronic Disease; Clostridium; Enterobacteriaceae; Enterococcus; Feces; HeLa Cells; Humans; Intestines; Microbial Sensitivity Tests; Middle Aged | 1995 |
Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease.
Topics: Administration, Oral; Adolescent; Anemia, Sickle Cell; Anti-Infective Agents; Bacteremia; Bacterial Infections; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Outpatients; Patient Compliance | 1996 |
Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
Topics: Adolescent; Adult; Area Under Curve; Cefixime; Cefotaxime; Cephalosporins; Child; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Male; Urinary Tract Infections | 1996 |
Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Penicillins; Pneumonia, Pneumococcal; Radiography | 1996 |
Comparison of the efficacy, safety and acceptability of cefixime and amoxicillin/clavulanate in acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Prospective Studies; Treatment Outcome | 1997 |
Single dose of betamethasone in combined medical treatment of secretory otitis media.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Betamethasone; Cefixime; Cefotaxime; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Male; Moraxella catarrhalis; Otitis Media with Effusion; Placebos; Recurrence; Streptococcus pneumoniae; Treatment Outcome | 1997 |
A randomized controlled trial of antibiotics on symptom resolution in patients presenting to their general practitioner with a sore throat.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cefotaxime; Family Practice; Female; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Treatment Outcome | 1997 |
Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. The STD Study Group.
Topics: Administration, Oral; Adolescent; Anti-Infective Agents; beta-Lactam Resistance; Cefixime; Cefotaxime; Cephalosporins; Fluoroquinolones; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillin Resistance; Piperazines; Quinolones | 1997 |
Cefixime: an oral option for the treatment of multidrug-resistant enteric fever in children.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Cost-Benefit Analysis; Drug Resistance, Multiple; Female; Humans; Male; Prospective Studies; Salmonella typhi; Treatment Outcome; Typhoid Fever | 1997 |
Plasma cytokines in paediatric typhoidal salmonellosis: correlation with clinical course and outcome.
Topics: Adolescent; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cohort Studies; Drug Resistance, Multiple; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Interleukin-6; Male; Morbidity; Salmonella typhi; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Typhoid Fever | 1997 |
Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests; Nasopharynx; Otitis Media; Streptococcus pneumoniae; Treatment Outcome | 1998 |
Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Roxithromycin; Streptococcus pneumoniae | 1998 |
Comparative efficacy of cefixime and ampicillin-sulbactam in shigellosis in children.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Child; Child, Preschool; Double-Blind Method; Dysentery, Bacillary; Female; Humans; Infant; Male; Prospective Studies; Sulbactam | 1998 |
Serum bactericidal activity of newer oral cephalosporins in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Cefixime; Cefotaxime; Ceftizoxime; Cefuroxime; Cephalosporins; Cross-Over Studies; Female; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Male; Serum Bactericidal Test; Streptococcus | 1998 |
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxacin; Female; HIV-1; Humans; Incidence; Injections, Intramuscular; Male; Metronidazole; Middle Aged; Penicillin G Benzathine; Prevalence; Sexual Behavior; Sexually Transmitted Diseases; Single-Blind Method; Uganda | 1998 |
A comparative study of cefixime and chloramphenicol in children with typhoid fever.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Female; Humans; Infant; Male; Treatment Outcome; Typhoid Fever | 1998 |
Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis.
Topics: Administration, Oral; Bronchitis; Cefixime; Cefotaxime; Cephalosporins; Chronic Disease; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Humans | 1998 |
Cefixime in the treatment of respiratory and urinary tract infections.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Child; Humans; Otitis Media; Pneumococcal Infections; Respiratory Tract Infections; Treatment Outcome; Urinary Tract Infections | 1998 |
A comparative study of cefixime and chloramphenicol in children with typhoid fever.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Female; Humans; Male; Remission Induction; Safety; Time Factors; Typhoid Fever | 1998 |
[Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis].
Topics: Acute Disease; Adult; Aged; Amoxicillin; Bacteremia; Cefixime; Cefotaxime; Cephalosporins; Communicable Diseases; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netilmicin; Pyelonephritis | 1998 |
Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis.
Topics: Administration, Oral; Adult; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intravenous; Lyme Disease; Penicillins; Probenecid; Renal Agents; Treatment Outcome | 1998 |
A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group.
Topics: Adolescent; Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Male; Ofloxacin; Typhoid Fever | 1999 |
Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Child; Exudates and Transudates; Female; Humans; Male; Otitis Media with Effusion; Time Factors | 1999 |
Oral versus initial intravenous therapy for urinary tract infections in young febrile children.
Topics: Acute Disease; Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Cost-Benefit Analysis; Female; Humans; Infant; Infusions, Intravenous; Logistic Models; Male; Patient Compliance; Pyelonephritis; Recurrence; Urinary Tract Infections | 1999 |
[A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections].
Topics: Adolescent; Adult; Bacterial Infections; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli; Female; Humans; Klebsiella; Male; Respiratory Tract Infections; Streptococcus pyogenes; Urinary Tract Infections | 1997 |
A clinical trial comparing oral azithromycin, cefixime and no antibiotics in the treatment of acute uncomplicated Salmonella enteritis in children.
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Cephalosporins; Enteritis; Female; Humans; Infant; Male; Prospective Studies; Salmonella Infections | 1999 |
Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Clinical Protocols; Drug Administration Schedule; Female; Health Care Costs; Humans; Infant; Injections, Intravenous; Length of Stay; Male; Pneumonia; Treatment Outcome | 1999 |
Comparison of intravenous aminoglycoside therapy with switch therapy to cefixime in urinary tract infections.
Topics: Adolescent; Age Factors; Aminoglycosides; Cefixime; Cefotaxime; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Prospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Urinalysis; Urinary Tract Infections | 2004 |
248 other study(ies) available for cefixime and cefotaxime
| Article | Year |
|---|---|
Evaluation of cefixime biliary disposition in the isolated perfused rabbit liver model and in humans.
Topics: Animals; Anti-Bacterial Agents; Bile; Biotransformation; Body Fluids; Cefixime; Cefotaxime; Cholecystectomy; Chromatography, High Pressure Liquid; Duodenum; Female; Gallbladder; Humans; In Vitro Techniques; Liver; Male; Middle Aged; Models, Biological; Perfusion; Rabbits | 1992 |
Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Topics: beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1992 |
[A clinical study on postantibiotic effect (PAE) and its application to chemotherapy for complicated cystitis with an automatic simulator of urinary drug concentration].
Topics: Amoxicillin; Anti-Infective Agents, Urinary; Automation; Cefixime; Cefotaxime; Cystitis; Enterobacter cloacae; Humans; Models, Biological; Ofloxacin; Staphylococcus epidermidis; Urinary Bladder | 1992 |
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Drug Evaluation, Preclinical; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests | 1992 |
In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
Topics: Ampicillin Resistance; Cefaclor; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Regression Analysis | 1992 |
Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Child; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis | 1992 |
Modification of cefixime bioavailability by nifedipine in humans: involvement of the dipeptide carrier system.
Topics: Administration, Oral; Adult; Biological Availability; Biological Transport, Active; Cefixime; Cefotaxime; Dipeptides; Drug Carriers; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Intestinal Absorption; Male; Nifedipine; Sensitivity and Specificity; Xylose | 1992 |
The activity of cefixime against 715 urinary isolates of Enterobacteriaceae isolated from general practice and out-patients in twenty centres across the British Isles.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; England; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Urine | 1992 |
[Alteration of bacteria induced by subinhibitory concentrations of cefixime: consequences on bactericidal activity of human polynuclear neutrophils].
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Chemotaxis; Dose-Response Relationship, Drug; Escherichia coli; Humans; Hydrogen Peroxide; In Vitro Techniques; Neutrophils; Oxidative Phosphorylation; Staphylococcus aureus | 1992 |
[Effect of the administration of cefixime on aerobic fecal flora in children].
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Child, Preschool; Drug Resistance, Microbial; Enterobacteriaceae; Feces; Humans; Respiratory Tract Infections; Staphylococcus; Streptococcus | 1992 |
[Biliary excretion and hepatic disposal of cefixime: experimental and clinical study].
Topics: Administration, Oral; Adult; Animals; Anti-Infective Agents, Urinary; Bacterial Infections; Bile; Biliary Tract Diseases; Cefixime; Cefotaxime; Cholecystectomy; Duodenum; Humans; In Vitro Techniques; Injections, Intravenous; Liver; Middle Aged; Postoperative Care; Rabbits; Reference Values | 1992 |
Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens.
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Drug Interactions; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Models, Biological; Respiratory Tract Infections; Urinary Bladder; Urinary Tract Infections | 1992 |
[Antimicrobial activity of cefetamet against fresh clinical isolates of Branhamella catarrhalis].
Topics: beta-Lactamases; Cefixime; Cefotaxime; Cefotiam; Cefpodoxime; Ceftizoxime; Drug Resistance, Microbial; Drug Stability; Humans; Moraxella catarrhalis; Respiratory Tract Infections | 1992 |
Determination of cefixime and its metabolites by high-performance capillary electrophoresis.
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Electrophoresis; Humans | 1992 |
Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes.
Topics: Amino Acids; Anti-Infective Agents, Urinary; Biological Transport; Cefixime; Cefotaxime; Cefotiam; Cell Line; Cell Membrane; Cells, Cultured; Cephalexin; Cephradine; Epithelium; Intestinal Mucosa; Intestines | 1992 |
Effect of blood contamination on the interpretation of antibiotic concentrations in middle ear fluid.
Topics: Acute Disease; Blood; Cefixime; Cefotaxime; Child, Preschool; Humans; Infant; Otitis Media, Suppurative | 1992 |
Antibacterial activity of cefixime against Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae in the presence of Moraxella (Branhamella) catarrhalis.
Topics: beta-Lactamases; Cefixime; Cefotaxime; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae; Streptococcus pyogenes | 1992 |
In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
Topics: Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Haemophilus; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Species Specificity; Streptococcus pneumoniae | 1992 |
H+ coupled transport of orally active cephalosporins lacking an alpha-amino group across brush-border membrane vesicles from rat small intestine.
Topics: Animals; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Hydrogen; In Vitro Techniques; Intestine, Small; Male; Membranes; Microvilli; Rats; Rats, Inbred Strains | 1991 |
Transport characteristics of ceftibuten, cefixime and cephalexin across human jejunal brush-border membrane.
Topics: Biological Transport, Active; Cefixime; Cefotaxime; Ceftibuten; Cephalexin; Cephalosporins; Glucose; Humans; Hydrogen; In Vitro Techniques; Jejunum; Microvilli | 1991 |
[Cefixime concentration in human prostatic tissue following 3-days of administration].
Topics: Administration, Oral; Aged; Aged, 80 and over; Cefixime; Cefotaxime; Humans; Male; Middle Aged; Prostate; Prostatectomy; Prostatic Hyperplasia | 1991 |
Third-generation cephalosporins in the treatment of acute pneumococcal otitis media. An animal study.
Topics: Acoustic Impedance Tests; Acute Disease; Ampicillin; Animals; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Chinchilla; Drug Evaluation, Preclinical; Otitis Media with Effusion; Pneumococcal Infections | 1992 |
Cefixime shows good effects on group A and group B beta-haemolytic streptococci.
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Cell Adhesion; Cell Division; Cheek; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Microbial Sensitivity Tests; Mouth Mucosa; Streptococcus agalactiae; Streptococcus pyogenes | 1991 |
[Penetration of cefixime in the anterior chamber of the human eye].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anterior Chamber; Anti-Infective Agents, Urinary; Aqueous Humor; Cataract Extraction; Cefixime; Cefotaxime; Cephalosporins; Humans; Middle Aged; Surgical Sponges | 1991 |
In vitro activity and cross resistance studies with cefpodoxime.
Topics: Anti-Infective Agents, Urinary; Bacteria; Cefixime; Cefotaxime; Cefotiam; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests | 1991 |
Relationship between renal function and disposition of oral cefixime.
Topics: Administration, Oral; Adult; Anti-Infective Agents, Urinary; Biological Assay; Cefixime; Cefotaxime; Chromatography, High Pressure Liquid; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Time Factors; Uremia | 1991 |
[Epidemiology, bacteriology and clinical experience with cefixime in the treatment of acute infantile otitis media].
Topics: Acute Disease; Anti-Infective Agents; Cefixime; Cefotaxime; Child; Child, Preschool; Humans; Infant; Otitis Media | 1991 |
[Bacteriological aspects of acute otitis media [corrected].
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Child; Humans; In Vitro Techniques | 1991 |
Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
Topics: Anti-Infective Agents, Urinary; Bacteria; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 1991 |
Pneumococcal bacteremia during oral treatment with cefixime for otitis media.
Topics: Administration, Oral; Cefixime; Cefotaxime; Drug Resistance, Microbial; Humans; Infant; Male; Otitis Media; Pneumococcal Infections; Sepsis; Streptococcus pneumoniae | 1991 |
An improved selective medium for the isolation of Escherichia coli O157.
Topics: Anti-Infective Agents, Urinary; Bacterial Toxins; Cefixime; Cefotaxime; Culture Media; Diarrhea; Escherichia coli; Escherichia coli Infections; Feces; Microbial Sensitivity Tests; Rhamnose; Shiga Toxin 1 | 1991 |
[Effects of cefixime and cefaclor on pharyngeal flora in children].
Topics: Adolescent; Bacteria; Cefaclor; Cefixime; Cefotaxime; Child; Child, Preschool; Humans; Infant; Pharyngitis; Pharynx | 1991 |
Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.
Topics: Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 1991 |
False resistance results using 5 micrograms cefixime disks to test Haemophilus influenzae.
Topics: Cefixime; Cefotaxime; False Positive Reactions; Haemophilus influenzae; Microbial Sensitivity Tests | 1991 |
Sexually transmitted diseases in the 1990s.
Topics: Cefixime; Cefotaxime; Ceftriaxone; Gonorrhea; HIV Infections; Humans; Sexually Transmitted Diseases | 1991 |
Recently introduced products.
Topics: Albuterol; Asthma; Bacterial Infections; Breast Diseases; Carboprost; Cefixime; Cefotaxime; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Humans; Linoleic Acids; Oenothera biennis; Pain; Plant Oils; Postpartum Hemorrhage; Pregnancy; Salmeterol Xinafoate | 1991 |
Synthesis and biological activity of novel 3-(2-propenyl)-cephalosporins. I.
Topics: Absorption; Administration, Oral; Alkenes; Animals; Bacteria; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Chromatography; Drug Evaluation, Preclinical; Kinetics; Mice; Microbial Sensitivity Tests; Molecular Structure; Rats | 1991 |
[Pharmacokinetic studies on oral antibiotics in pediatrics. I. A pharmacokinetic study on cefixime in pediatrics].
Topics: Administration, Oral; Adolescent; Age Factors; Cefixime; Cefotaxime; Child; Child, Preschool; Dose-Response Relationship, Drug; Eating; Humans; Infant | 1991 |
[A case of eosinophilic pneumonitis with drug hypersensitivity].
Topics: Alveolitis, Extrinsic Allergic; Atropine; Cefixime; Cefotaxime; Drug Hypersensitivity; Female; Humans; Lidocaine; Middle Aged; Prednisolone; Pulmonary Eosinophilia | 1991 |
[Clinical evaluation of cefixime in pediatric respiratory tract infections].
Topics: Age Factors; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Haemophilus influenzae; Humans; Infant; Male; Respiratory Tract Infections; Streptococcus pneumoniae | 1991 |
In vitro activity of cefixime: correlation index between MIC and disc diffusion test.
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1990 |
[Cefixime. Clinical and microbiological examination].
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Humans | 1990 |
[Cefixime therapy in sinusitis].
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Cefixime; Cefotaxime; Chronic Disease; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Recurrence; Sinusitis | 1990 |
[Cefixime therapy in patients with proven gonorrhea].
Topics: Acute Disease; Adult; Anti-Infective Agents; Cefixime; Cefotaxime; Drug Tolerance; Gonorrhea; Humans; Male; Middle Aged | 1990 |
[Therapy of pediatric infections with cefixime].
Topics: Anti-Infective Agents; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Humans; Lymphadenitis; Otitis Media; Pneumonia; Respiratory Tract Infections; Sinusitis; Urinary Tract Infections | 1990 |
[Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
Topics: Administration, Oral; Adult; Anti-Infective Agents; Biological Availability; Cefixime; Cefotaxime; Cephalosporins; Esters; Female; Half-Life; Humans; Male; Molecular Structure; Prodrugs; Solutions; Suspensions; Tablets | 1990 |
[Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefixime; Cefotaxime; Cephalosporins; Drug Stability; Molecular Structure | 1990 |
Activity of cefixime against Helicobacter pylori and affinities for the penicillin-binding proteins.
Topics: Anti-Infective Agents, Urinary; Bacterial Proteins; Carrier Proteins; Cefixime; Cefotaxime; Culture Media; Escherichia coli; Helicobacter pylori; Hexosyltransferases; Microscopy, Electron, Scanning; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases | 1990 |
[Spondylodiscitis caused by Enterobacter cloacae treated with cefixime].
Topics: Aged; Cefixime; Cefotaxime; Discitis; Enterobacter; Enterobacteriaceae Infections; Humans; Male | 1990 |
In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.
Topics: Administration, Oral; Cefixime; Cefotaxime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Helicobacter pylori; Microbial Sensitivity Tests | 1990 |
Free cefixime in community health centers.
Topics: Anti-Infective Agents; Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Community Health Services; Costs and Cost Analysis; Humans | 1990 |
Analysis of enterohepatic circulation of cefixime in rat by fast inverse Laplace transform (FILT).
Topics: Animals; Biological Availability; Cefixime; Cefotaxime; Chromatography, High Pressure Liquid; Enterohepatic Circulation; Indicators and Reagents; Liver; Male; Mathematics; Models, Biological; Rats; Rats, Inbred Strains; Spectrophotometry, Ultraviolet | 1990 |
Concentrations of cefixime in bronchial mucosa and sputum.
Topics: Anti-Infective Agents, Urinary; Bronchi; Cefixime; Cefotaxime; Humans; Sputum | 1990 |
Transport mechanisms of bestatin in rabbit intestinal brush-border membranes: role of H+/dipeptide cotransport system.
Topics: Adjuvants, Immunologic; Aminopeptidases; Animals; Biological Transport; Cefixime; Cefotaxime; Cephradine; Dipeptides; Hydrogen-Ion Concentration; Intestinal Mucosa; Leucine; Male; Microvilli; Rabbits | 1990 |
Cefixime: in vitro sensitivity of respiratory and urinary tract infection organisms.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Urinary Tract Infections | 1990 |
Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.
Topics: Administration, Oral; Animals; beta-Lactamases; Cefixime; Cefmenoxime; Cefotaxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Kinetics; Male; Mice; Microbial Sensitivity Tests; Staphylococcal Infections | 1990 |
Relative bioavailability of three cefixime formulations.
Topics: Administration, Oral; Adult; Biological Availability; Cefixime; Cefotaxime; Dosage Forms; Female; Gels; Half-Life; Humans; Intestinal Absorption; Male; Powders; Tablets | 1990 |
New orally active cephalosporin esters.
Topics: Absorption; Administration, Oral; Animals; Bacteria; Cefixime; Cefmenoxime; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Esters; Mice; Rats | 1990 |
Concentration of cefixime in bile, gallbladder wall and serum after preoperative administration in patients undergoing cholecystectomy.
Topics: Adult; Aged; Bile; Cefixime; Cefotaxime; Cholecystectomy; Chromatography, High Pressure Liquid; Female; Gallbladder; Humans; Male; Middle Aged | 1990 |
Concentrations of cefixime in bronchial mucosa and sputum after three oral multiple dose regimens.
Topics: Administration, Oral; Bronchi; Cefixime; Cefotaxime; Drug Administration Schedule; Humans; Mucous Membrane; Sputum | 1990 |
Comparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients.
Topics: Ampicillin Resistance; beta-Lactamases; Cefixime; Cefotaxime; Ceftriaxone; Haemophilus Infections; Haemophilus influenzae; Microbial Sensitivity Tests | 1990 |
Lack of effect of cefixime on the metabolism of vitamin K1.
Topics: Administration, Oral; Adult; Cefixime; Cefotaxime; Drug Administration Schedule; Humans; Male; Premedication; Vitamin K; Vitamin K 1 | 1990 |
Efficacy and safety of a single 400 mg oral dose of cefixime in the treatment of uncomplicated gonorrhea.
Topics: Administration, Oral; Adolescent; Adult; Cefixime; Cefotaxime; Gonorrhea; Humans; Male; Neisseria gonorrhoeae | 1989 |
Comparative activity of cefixime and cefaclor in an in vitro model simulating human pharmacokinetics.
Topics: Cefaclor; Cefixime; Cefotaxime; Cephalexin; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella pneumoniae; Proteus mirabilis; Streptococcus pyogenes | 1989 |
[Antibacterial effect of cefixime].
Topics: Cefixime; Cefotaxime; Cell Membrane Permeability; Enterobacteriaceae; Escherichia coli; Haemophilus; Humans; Microbial Sensitivity Tests; Neisseriaceae; Pasteurella; Pseudomonas aeruginosa; Staphylococcus; Streptococcaceae | 1989 |
[In vitro effect of cefixime against Haemophilus influenzae].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 1989 |
[In vitro comparative effect of cefixime and 7 other beta-lactamines against Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae | 1989 |
[Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Dose-Response Relationship, Drug; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella; Klebsiella pneumoniae; Penicillin Resistance; Phenotype | 1989 |
[Critical concentrations of cefixime and disc potency].
Topics: Bacterial Infections; Bacteriological Techniques; Cefixime; Cefotaxime; Dose-Response Relationship, Drug; Humans | 1989 |
[In vitro comparative bactericidal effect of cefotaxime and cefixime in a kinetic model].
Topics: Cefixime; Cefotaxime; Dose-Response Relationship, Drug; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens | 1989 |
[Effect of sub-inhibitory concentrations of cefixime on the morphology, hemagglutination and adhesiveness of urinary strains of Escherichia coli].
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Cefixime; Cefotaxime; Escherichia coli; Guinea Pigs; Hemagglutination; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning | 1989 |
[Pharmacokinetic properties of cefixime].
Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Cefixime; Cefotaxime; Child; Child, Preschool; Chromatography, High Pressure Liquid; Creatinine; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Male; Middle Aged; Palatine Tonsil; Reference Values | 1989 |
[Pharmacokinetics of cefixime in healthy volunteers after a single oral administration of 200 mg].
Topics: Administration, Oral; Adult; Biological Availability; Cefixime; Cefotaxime; Humans; Male; Metabolic Clearance Rate; Protein Binding; Time Factors | 1989 |
[Effect of hepatic failure upon the pharmacokinetics of cefixime].
Topics: Adult; Aged; Cefixime; Cefotaxime; Female; Half-Life; Humans; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged | 1989 |
[Tonsillar diffusion of cefixime in children].
Topics: Biological Transport; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Male; Palatine Tonsil | 1989 |
[Structure-activity relationship of oral cephalosporins].
Topics: Absorption; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Structure-Activity Relationship | 1989 |
In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae.
Topics: Ampicillin; Bacterial Proteins; Carrier Proteins; Cefixime; Cefotaxime; Cephalosporins; Culture Media; Haemophilus influenzae; Hexosyltransferases; Kinetics; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Phenotype | 1989 |
[Clinical experience with cefixime in urinary tract infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefixime; Cefotaxime; Cystitis; Drug Evaluation; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 1989 |
Systemic antibiotics for treatment of the conjunctivitis-otitis media syndrome.
Topics: Administration, Oral; Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Child; Child, Preschool; Conjunctivitis, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Otitis Media; Streptococcus pneumoniae | 1989 |
[Treatment of urinary tract infection with cefixime].
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Drug Evaluation; Escherichia coli Infections; Humans; Urinary Tract Infections | 1989 |
Cefixime, in-vitro activity, pharmacokinetics and tissue penetration.
Topics: Adult; Bacteria; Cefixime; Cefotaxime; Humans; Male | 1989 |
Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Female; Half-Life; Lung Diseases; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal | 1989 |
[Tonsil diffusion of cefixime in children].
Topics: Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Male; Palatine Tonsil | 1989 |
Saturable uptake of cefixime, a new oral cephalosporin without an alpha-amino group, by the rat intestine.
Topics: Animals; Butanols; Cefixime; Cefotaxime; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Intestinal Mucosa; Kinetics; Male; Rats; Rats, Inbred Strains; Sodium; Solubility; Structure-Activity Relationship | 1987 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
[The effect of cefixime (CFIX) on intestinal bacterial flora].
Topics: Bronchitis; Bronchopneumonia; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Resistance, Microbial; Enterobacteriaceae; Feces; Female; Heart Septal Defects, Ventricular; Humans; Infant; Intestines; Male | 1986 |
In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Cefixime; Cefotaxime; Chlamydia trachomatis; Ciprofloxacin; Female; Fluoroquinolones; Gardnerella vaginalis; Genitalia; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1986 |
Comparative in vitro activity of the new oral cephalosporin cefixime.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acids; Drug Resistance, Microbial; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Salmonella typhi | 1988 |
In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Topics: Administration, Oral; Cefaclor; Cefixime; Cefotaxime; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseria meningitidis; Streptococcus | 1988 |
[An infection route of meningococcal meningitis and eradication of carriers].
Topics: Carrier State; Cefixime; Cefotaxime; Female; Humans; Meningitis, Meningococcal; Middle Aged; Ofloxacin | 1988 |
Application of high-performance liquid chromatography of some antibiotics in clinical microbiology.
Topics: Anti-Bacterial Agents; Buffers; Cefixime; Cefotaxime; Chromatography, High Pressure Liquid; Humans; Imipenem; Indicators and Reagents; Penicillins; Saliva; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Thienamycins | 1988 |
H+ coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Administration, Oral; Animals; Biological Transport; Cefixime; Cefotaxime; Cephalosporins; Cephradine; Dipeptides; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Mucosa; Male; Microvilli; Rabbits; Structure-Activity Relationship | 1988 |
The pharmacokinetics of cefixime in the fasted and fed state.
Topics: Administration, Oral; Adolescent; Adult; Cefixime; Cefotaxime; Fasting; Food; Humans; Male | 1988 |
Absolute bioavailability of cefixime in man.
Topics: Administration, Oral; Adult; Biological Availability; Cefixime; Cefotaxime; Humans; Injections, Intravenous; Male; Models, Biological; Protein Binding | 1988 |
In vitro activity of cefixime, a new oral cephalosporin.
Topics: Administration, Oral; Bacteria; Cefixime; Cefotaxime; Microbial Sensitivity Tests | 1988 |
Impact of cefixime on the normal intestinal microflora.
Topics: Administration, Oral; Adult; Cefixime; Cefotaxime; Feces; Humans; Intestines; Male | 1988 |
In vitro antibacterial activity of cefixime.
Topics: Amoxicillin; Ampicillin; Bacteria; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Humans; Microbial Sensitivity Tests | 1988 |
Activity of cefixime (FK 027) for resistant gram-negative bacilli.
Topics: Ampicillin Resistance; Cefixime; Cefotaxime; Enterobacteriaceae; Gram-Negative Bacteria; Kinetics; Microbial Sensitivity Tests | 1988 |
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
Topics: Bacteria; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Ceftriaxone; Microbial Sensitivity Tests | 1988 |
In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Child; Drug Combinations; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acids; Culture Media; Drug Combinations; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Plasmids | 1988 |
Carrier-mediated transport of cefixime, a new cephalosporin antibiotic, via an organic anion transport system in the rat renal brush-border membrane.
Topics: Animals; Biological Transport, Active; Cefixime; Cefotaxime; Cephalosporins; Hydrogen-Ion Concentration; Kidney; Male; Microvilli; Potassium; Rats; Rats, Inbred Strains; Valinomycin | 1988 |
Pharmacokinetics of cefixime in the young and elderly.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cefixime; Cefotaxime; Humans; Male; Protein Binding | 1988 |
Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady state.
Topics: Adult; Cefixime; Cefotaxime; Chromatography, High Pressure Liquid; Drug Administration Schedule; Humans; Male | 1987 |
Determination of cefixime in biological samples by reversed-phase high-performance liquid chromatography.
Topics: Cefixime; Cefotaxime; Chromatography, High Pressure Liquid; Drug Stability; Humans; Indicators and Reagents; Reference Standards; Spectrophotometry, Ultraviolet | 1987 |
Efficacy of a new cephalosporin for acute otitis media.
Topics: Ampicillin; Animals; beta-Lactamases; Cefixime; Cefotaxime; Chinchilla; Haemophilus Infections; Haemophilus influenzae; Otitis Media with Effusion | 1987 |
In vitro activity of cefixime and six other agents against nosocomial pathogens of the Enterobacteriaceae family.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cephalothin; Cross Infection; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefixime; Cefotaxime; Enoxacin; Haemophilus influenzae; Leucomycins; Microbial Sensitivity Tests; Naphthyridines | 1987 |
In vitro susceptibility of Haemophilus influenzae to cefixime.
Topics: Cefixime; Cefotaxime; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 1987 |
Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dog.
Topics: Administration, Oral; Animals; Biological Availability; Cefixime; Cefotaxime; Dogs; Dose-Response Relationship, Drug; Half-Life; Injections, Intravenous | 1987 |
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.
Topics: Amoxicillin; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalexin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Escherichia coli; In Vitro Techniques; Pseudomonas; Staphylococcus | 1986 |
[Clinical studies of cefixime in pediatric field].
Topics: Acute Disease; Adolescent; Cefixime; Cefotaxime; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Eosinophilia; Female; Humans; Infant; Male; Scarlet Fever; Staphylococcus aureus; Streptococcus pyogenes; Tonsillitis | 1986 |
Penetration of cefixime into fibrin clots and in vivo efficacy against Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus.
Topics: Animals; Cefixime; Cefotaxime; Escherichia coli; Female; Fibrin; Half-Life; Kinetics; Klebsiella pneumoniae; Rabbits; Staphylococcus aureus | 1986 |
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates.
Topics: Bacteria; Cefixime; Cefmenoxime; Cefotaxime; Cephalexin; Cephaloridine; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests | 1987 |
In vitro stability of cefixime (FK-027) in serum, urine and buffer.
Topics: Buffers; Cefixime; Cefotaxime; Chromatography, High Pressure Liquid; Drug Stability; Humans; Spectrophotometry, Ultraviolet; Temperature | 1987 |
H+ gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine.
Topics: Amino Acids; Animals; Biological Transport, Active; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cefixime; Cefotaxime; Dipeptides; Hydrogen-Ion Concentration; Intestine, Small; Kinetics; Male; Mathematics; Membrane Potentials; Microvilli; Oligopeptides; Osmolar Concentration; Rats; Rats, Inbred Strains; Temperature | 1987 |
Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor.
Topics: Bacteria; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Clostridium; Digestive System; Enterobacteriaceae; Feces; Humans; Intestines; Male | 1987 |
Degradation kinetics and mechanisms of a new cephalosporin, cefixime, in aqueous solution.
Topics: Cefixime; Cefotaxime; Chemical Phenomena; Chemistry; Chromatography; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Solutions; Spectrum Analysis | 1987 |
Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
Topics: Administration, Oral; Animals; Biological Availability; Blood Proteins; Cefixime; Cefotaxime; Dogs; Infusions, Intravenous; Kinetics; Protein Binding | 1987 |
Liquid-chromatographic determination of five orally active cephalosporins--cefixime, cefaclor, cefadroxil, cephalexin, and cephradine--in human serum.
Topics: Cefaclor; Cefadroxil; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid; Humans; Reference Standards; Reference Values | 1987 |
Evidence for a carrier-mediated transport system in the small intestine available for FK089, a new cephalosporin antibiotic without an amino group.
Topics: Animals; Cefixime; Cefotaxime; Chemical Phenomena; Chemistry; Hydrogen-Ion Concentration; Intestinal Absorption; Intestine, Small; Kinetics; Male; Rats; Rats, Inbred Strains | 1986 |
Proceedings of a conference: Clinical pharmacology and efficacy of cefixime. Sonoma, CA, March 20 and 21, 1987.
Topics: Cefixime; Cefotaxime; Humans | 1987 |
Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates.
Topics: Bacteria; Cefixime; Cefotaxime; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Staphylococcus | 1987 |
In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
Topics: Bacteria; Cefixime; Cefotaxime; Cephalosporins; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria | 1987 |
Pharmacokinetic profile of cefixime in man.
Topics: Adolescent; Adult; Biological Availability; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Protein Binding | 1987 |
Bacteriologic and clinical efficacy of cefixime compared with amoxicillin in acute otitis media.
Topics: Acute Disease; Amoxicillin; Bacteria; Cefixime; Cefotaxime; Humans; Microbial Sensitivity Tests; Otitis Media with Effusion; Patient Compliance | 1987 |
[Clinical evaluation of cefixime in children].
Topics: Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Haemophilus Infections; Humans; Infant; Kinetics; Male; Pneumonia; Pneumonia, Mycoplasma; Respiratory Tract Infections; Urinary Tract Infections | 1986 |
[Clinical studies of cefixime granules in pediatrics].
Topics: Administration, Oral; Bacterial Infections; Capsules; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Kinetics; Male; Respiratory Tract Infections; Urinary Tract Infections | 1986 |
[Fundamental and clinical studies of cefixime granules in pediatrics].
Topics: Adolescent; Bacteria; Bacterial Infections; Capsules; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Kinetics; Male; Respiratory Tract Infections; Species Specificity; Urinary Tract Infections | 1986 |
[Fundamental and clinical studies on cefixime (5% granules) in the pediatric field].
Topics: Administration, Oral; Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Intestinal Absorption; Kinetics; Male; Respiratory Tract Infections; Species Specificity; Urinary Tract Infections | 1986 |
[Fundamental and clinical studies on cefixime in the pediatric field].
Topics: Acute Disease; Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Kinetics; Male; Pharyngitis; Species Specificity; Tonsillitis; Urinary Tract Infections | 1986 |
[Fundamental and clinical studies on cefixime in pediatrics].
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Intestinal Absorption; Kinetics; Male; Respiratory Tract Infections; Species Specificity; Urinary Tract Infections | 1986 |
[Clinical study on cefixime granules in the field of pediatrics].
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Kinetics; Male; Tonsillitis; Urinary Tract Infections | 1986 |
[Clinical experience with cefixime in the pediatric infections].
Topics: Acute Disease; Adolescent; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Kinetics; Male; Pneumonia; Respiratory Tract Infections; Tonsillitis; Urinary Tract Infections | 1986 |
[Clinical experience with cefixime in the pediatric field].
Topics: Acute Disease; Adolescent; Bacterial Infections; Bronchopneumonia; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Male; Respiratory Tract Infections; Tonsillitis; Urinary Tract Infections | 1986 |
[Clinical studies on cefixime in pediatrics].
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Diarrhea; Female; Humans; Infant; Male; Otitis Media; Respiratory Tract Infections; Skin Diseases; Urinary Tract Infections | 1986 |
[Fundamental and clinical studies on cefixime in pediatrics].
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Intestinal Absorption; Kidney; Kinetics; Male; Respiratory Tract Infections; Urinary Tract Infections | 1986 |
[Fundamental and clinical studies on cefixime in pediatric field].
Topics: Acute Disease; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Enteritis; Female; Humans; Infant; Kinetics; Male; Pharyngitis; Respiratory Tract Infections; Tonsillitis; Urinary Tract Infections | 1986 |
[Pharmacokinetics and clinical effects of cefixime in pediatrics].
Topics: Acute Disease; Adolescent; Bacterial Infections; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Intestinal Absorption; Kinetics; Male; Scarlet Fever; Tonsillitis; Urinary Tract Infections | 1986 |
[Fundamental and clinical studies of cefixime in children].
Topics: Administration, Oral; Adolescent; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infant; Kinetics; Lymphadenitis; Male; Pharyngitis; Pneumonia; Respiratory Tract Infections; Urinary Tract Infections | 1986 |
Cefixime disk susceptibility test criteria.
Topics: Bacteria; Cefixime; Cefotaxime; Drug Resistance, Microbial; Microbial Sensitivity Tests; Regression Analysis | 1986 |
Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency.
Topics: Adult; Aged; Cefixime; Cefotaxime; Female; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Protein Binding | 1986 |
Studies on beta-lactam antibiotics. XIV. Synthesis and biological activity of the (E)-isomer of FK027.
Topics: Animals; Bacteria; Cefixime; Cefotaxime; Chemical Phenomena; Chemistry; Rats; Rats, Inbred Strains; Stereoisomerism | 1986 |
[Pharmacokinetics of cefixime in patients with impaired renal function].
Topics: Administration, Oral; Adult; Aged; Cefixime; Cefotaxime; Drug Administration Schedule; Female; Half-Life; Humans; Kidney Diseases; Kinetics; Male; Middle Aged | 1986 |
Beta-lactam antibiotics and transport via the dipeptide carrier system across the intestinal brush-border membrane.
Topics: Animals; Anti-Bacterial Agents; Biological Transport, Active; Carrier Proteins; Cefixime; Cefotaxime; Dipeptides; Intestines; Microvilli | 1987 |
Mechanism of renal excretion of FK027 in dogs and rabbits.
Topics: Absorption; Animals; Cefixime; Cefotaxime; Dogs; Kidney; Male; Metabolic Clearance Rate; p-Aminohippuric Acid; Probenecid; Rabbits; Species Specificity | 1985 |
The pharmacokinetic and bactericidal characteristics of oral cefixime.
Topics: Administration, Oral; Adult; Bacteria; Cefixime; Cefotaxime; Humans; Kinetics; Male | 1985 |
Relationship between protein binding and renal clearance of a new oral cephalosporin in the dog.
Topics: Animals; Cefixime; Cefotaxime; Cephalosporins; Dogs; Kidney; Kinetics; Protein Binding | 1985 |
Studies on beta-lactam antibiotics. IX. Synthesis and biological activity of a new orally active cephalosporin, cefixime (FK027).
Topics: Administration, Oral; Animals; Bacteria; Bile; Cefixime; Cefotaxime; Half-Life; Rats; Rats, Inbred Strains | 1985 |
Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Carbapenems; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acids; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; United States | 1995 |
Central nervous system Whipple's disease: relapse during therapy with trimethoprim-sulfamethoxazole and remission with cefixime.
Topics: Cefixime; Cefotaxime; Central Nervous System Diseases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Recurrence; Remission Induction; Trimethoprim, Sulfamethoxazole Drug Combination; Vision Disorders; Whipple Disease | 1994 |
Effect of membrane surface potential on the uptake of anionic compounds by liposomes.
Topics: Anions; Cefixime; Cefotaxime; Ceftibuten; Cell Membrane Permeability; Cephalosporins; Hydroxyindoleacetic Acid; Liposomes; Membrane Potentials; Phosphatidylserines | 1994 |
Living with Lyme.
Topics: Adaptation, Psychological; Adult; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Finland; History, 20th Century; Humans; Lyme Disease; Male | 1995 |
Clinical pharmacologic aspects of cefixime in dogs.
Topics: Animals; Anti-Infective Agents; Cefixime; Cefotaxime; Dogs; Female; Male; Microbial Sensitivity Tests; Protein Binding; Time Factors | 1995 |
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1994 |
Once-a-day cefixime versus co-amoxiclav three times daily in the treatment of lower respiratory infections.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefixime; Cefotaxime; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Respiratory Tract Infections; Sputum | 1995 |
Methods for predicting susceptibility of Streptococcus pneumoniae to cefixime.
Topics: Cefixime; Cefotaxime; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 1995 |
[Cefixime in the treatment of lower respiratory tract infections in patients with chronic bronchitis].
Topics: Aged; Anti-Infective Agents; Bronchitis; Cefixime; Cefotaxime; Chronic Disease; Drug Tolerance; Humans; Male; Middle Aged; Respiratory Tract Infections; Time Factors | 1995 |
In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefaclor; Cefixime; Cefmenoxime; Cefotaxime; Drug Stability; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Kinetics; Microbial Sensitivity Tests | 1994 |
Urinary tract infection caused by quinolone-resistant Campylobacter coli.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Cefixime; Cefotaxime; Female; Humans; Infant; Urinalysis; Urinary Tract Infections | 1994 |
[Re-evaluation of current antimicrobials. Series 21: cefixime. Discussion].
Topics: Administration, Oral; Bacteria; Cefixime; Cefotaxime; Drug Resistance, Microbial; Humans; Respiratory Tract Infections | 1994 |
Intestinal brush-border transport of the oral cephalosporin antibiotic, cefdinir, mediated by dipeptide and monocarboxylic acid transport systems in rabbits.
Topics: Acetates; Animals; Biological Transport, Active; Carboxylic Acids; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Cephradine; Dipeptides; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Male; Membrane Potentials; Microvilli; Rabbits | 1993 |
Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Culture Media; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control | 1994 |
Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; beta-Lactamases; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Resistance, Multiple; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests | 1994 |
PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli.
Topics: Bacterial Proteins; Biological Transport; Carrier Proteins; Cefixime; Cefotaxime; Ceftizoxime; Cefuroxime; Cell Membrane; Cell Membrane Permeability; Cephalosporins; Dose-Response Relationship, Drug; Escherichia coli; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases | 1994 |
Cefixime and antibiotic-associated colitis.
Topics: Cefixime; Cefotaxime; Child; Child, Preschool; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin | 1994 |
[Initial empiric treatment of pneumonia and the new antibiotics].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefuroxime; Clarithromycin; Fluoroquinolones; Humans; Pneumonia | 1994 |
Changes in the permeation rate of organic anions through the intestinal brush-border membrane with membrane surface potential.
Topics: Anilino Naphthalenesulfonates; Animals; Anions; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Diffusion; Fluorescent Dyes; Hydrogen-Ion Concentration; Intestinal Mucosa; Membrane Potentials; Microvilli; Penicillin G; Permeability; Rats | 1994 |
Penetration of cefixime into the cerebrospinal fluid of patients with non-inflamed meninges.
Topics: Adult; Cefixime; Cefotaxime; Female; Humans; Male; Meninges; Middle Aged; Reference Values | 1993 |
Recognition of severe cefixime-induced diarrhea.
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Diarrhea; Female; Humans; Middle Aged | 1993 |
In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cefuroxime; Culture Media; Microbial Sensitivity Tests; Models, Biological; Penicillin Resistance; Streptococcus pneumoniae | 1994 |
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates.
Topics: Anti-Infective Agents; Bacteria, Aerobic; Cefixime; Cefotaxime; Cefuroxime; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1993 |
Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase types.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Ceftizoxime; Clavulanic Acids; Colony Count, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Moraxella catarrhalis | 1994 |
Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.
Topics: Adenocarcinoma; Amino Acids; Biological Transport; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Colonic Neoplasms; Dipeptides; Drug Antagonism; Energy Metabolism; Humans; Intestinal Absorption; Tumor Cells, Cultured | 1994 |
An experimental study of cefixime in the treatment of Streptococcus pneumoniae otitis media.
Topics: Acoustic Impedance Tests; Acute Disease; Ampicillin; Animals; Anti-Infective Agents; Cefixime; Cefotaxime; Chinchilla; Ear, Middle; Endoscopy; Injections, Intramuscular; Otitis Media; Placebos; Pneumococcal Infections; Single-Blind Method; Time Factors | 1994 |
Role of intrahepatic protein binding in the hepatobiliary extraction profile of cefixime in humans.
Topics: Bile; Biliary Tract; Cefixime; Cefotaxime; Cholecystectomy; Female; Humans; Liver; Male; Middle Aged; Protein Binding | 1993 |
Cefixime in the treatment of enteric fever in children.
Topics: Adolescent; Anti-Bacterial Agents; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Salmonella typhi; Typhoid Fever | 1993 |
Interaction of the orally active dianionic cephalosporin cefixime with the uptake system for oligopeptides and alpha-amino-beta-lactam antibiotics in rabbit small intestine.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biological Transport; Cefixime; Cefotaxime; Cephalexin; Drug Interactions; Hot Temperature; Hydrogen-Ion Concentration; Intestine, Small; Oligopeptides; Rabbits | 1993 |
Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Finland; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 1993 |
Shedding of Clostridium difficile, fecal beta-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Clostridioides difficile; Diarrhea; Digestive System; Feces; Female; Humans; Male | 1993 |
Biliary excretion of cefixime: assessment in patients provided with T-tube drainage.
Topics: Administration, Oral; Anti-Infective Agents; Biliary Tract; Cefixime; Cefotaxime; Cholecystectomy; Drainage; Female; Humans; Male; Middle Aged | 1993 |
[Determination of cefixime in human plasma and urine using high performance liquid chromatography column switching technique].
Topics: Cefixime; Cefotaxime; Chromatography, High Pressure Liquid; Humans | 1993 |
Cefixime therapy for otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Infective Agents; Cefixime; Cefotaxime; Child; Chronic Disease; Humans; Otitis Media | 1993 |
Pharmacokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children.
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Cerebrospinal Fluid Shunts; Chromatography, High Pressure Liquid; Half-Life; Humans; Infant; Meningitis, Haemophilus; Spinal Puncture | 1993 |
Efficacy of ceftibuten for acute otitis media caused by Hemophilus influenzae: an animal study.
Topics: Acute Disease; Ampicillin; Animals; Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Chinchilla; Haemophilus Infections; Haemophilus influenzae; Otitis Media; Random Allocation | 1993 |
HPLC assay of cefixime in serum and CSF.
Topics: Cefixime; Cefotaxime; Chromatography, High Pressure Liquid; Humans | 1993 |
[Protein binding of oral cephems in patients with chronic renal failure].
Topics: Carrier Proteins; Cefdinir; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Humans; Kidney Failure, Chronic; Palmitic Acid; Palmitic Acids; Renal Dialysis | 1993 |
Safety and efficacy of cefixime in treatment of respiratory tract infections in Germany.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Female; Humans; Male; Respiratory Tract Infections | 1995 |
Assessment of the use of cefixime for switch therapy.
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Cephalosporins; Humans; Injections; Patient Compliance | 1995 |
Cost-effectiveness decision analysis of intramuscular ceftriaxone versus oral cefixime in adolescents with gonococcal cervicitis.
Topics: Administration, Oral; Adolescent; Anti-Infective Agents; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Cost of Illness; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Female; Gonorrhea; Humans; Injections, Intramuscular; Treatment Outcome; Uterine Cervicitis | 1996 |
A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from cases of bloody diarrhoea, non-bloody diarrhoea and asymptomatic contacts.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Bacterial Toxins; Bacteriophage Typing; Cefixime; Cefotaxime; Chlorocebus aethiops; Culture Media; Cytotoxins; Diarrhea; DNA Probes; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Gastrointestinal Hemorrhage; Humans; Immunomagnetic Separation; Plasmids; Rhamnose; Shiga Toxin 1; Sorbitol; Vero Cells | 1996 |
Short course chemotherapy with cefixime in children with multidrug-resistant Salmonella typhi Septicaemia.
Topics: Adolescent; Anti-Bacterial Agents; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Resistance, Microbial; Drug Resistance, Multiple; Egypt; Female; Humans; Male; Salmonella typhi; Sepsis; Treatment Outcome; Typhoid Fever | 1995 |
Third generation oral cephalosporins: comparative in vitro kinetics.
Topics: Administration, Oral; Cefixime; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalosporins; Escherichia coli; Haemophilus influenzae; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae; Streptococcus pyogenes | 1995 |
[Anaphylaxis caused by cefixime with tolerance to other beta lactams].
Topics: Adolescent; Anaphylaxis; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefotaxime; Drug Hypersensitivity; Drug Tolerance; Female; Humans | 1996 |
Switch therapy in community-acquired pneumonia.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Community-Acquired Infections; Hospitalization; Humans; Infusions, Intravenous; Pneumonia; Treatment Outcome; United Kingdom | 1996 |
Synthesis and biological activity of C-3 direct heterocyclylcarbon-substituted novel cephalosporins.
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests; Structure-Activity Relationship; Thiazoles | 1996 |
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Colony-Forming Units Assay; Humans; Microbial Sensitivity Tests; Models, Theoretical; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1996 |
Penetration and bactericidal activity of cefixime in synovial fluid.
Topics: Adult; Aged; Cefixime; Cefotaxime; Cephalosporins; Escherichia coli; Female; Haemophilus influenzae; Humans; Joint Diseases; Male; Middle Aged; Rheumatic Diseases; Synovial Fluid; Time Factors | 1996 |
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxacin; Cohort Studies; Drug Prescriptions; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Pregnancy; Product Surveillance, Postmarketing; Treatment Outcome | 1996 |
Susceptibility of respiratory strains of Staphylococcus aureus to fifteen antibiotics: results of a collaborative surveillance study (1992-1993). The Alexander Project Collaborative Group.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Drug Resistance, Microbial; Europe; Humans; Lactams; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Penicillin Resistance; Respiratory Tract Infections; Staphylococcus aureus; United States | 1996 |
Alternative continuous infusion method for analysis of enterohepatic circulation and biliary excretion of cefixime in the rat.
Topics: Animals; Bile; Cefixime; Cefotaxime; Cephalosporins; Enterohepatic Circulation; Male; Rats; Rats, Wistar | 1994 |
Increased intestinal absorption of cefixime by nifedipine in the rat intestinal perfusion model: evidence for a neural regulation.
Topics: Animals; Cefixime; Cefotaxime; Drug Synergism; Enteric Nervous System; Intestinal Absorption; Intestine, Small; Models, Biological; Nifedipine; Peptide YY; Peptides; Perfusion; Rats; Rats, Sprague-Dawley; Salicylates; Salicylic Acid | 1997 |
[Studies on enrichment broth for verotoxin-producing Escherichia coli (VTEC) O157].
Topics: Aeromonas; Anti-Bacterial Agents; Bacterial Toxins; Bacteriological Techniques; Cefixime; Cefotaxime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Escherichia coli O157; Novobiocin; Pseudomonas; Shiga Toxin 1; Tellurium; Temperature; Vancomycin | 1997 |
Cerebral relapse of sarcoidlike Whipple's disease.
Topics: Brain Diseases; Cefixime; Cefotaxime; Ceftriaxone; Diagnosis, Differential; Humans; Male; Middle Aged; Recurrence; Sarcoidosis; Whipple Disease | 1997 |
Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture.
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Fallopian Tubes; Female; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Organ Culture Techniques | 1997 |
Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; beta-Lactam Resistance; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Protein Binding; Streptococcus pneumoniae | 1997 |
[Infections in childhood; from respiratory infections to tropical medicine].
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Dexamethasone; Humans; Meningitis; Otitis Media; Respiratory Tract Infections | 1993 |
Middle ear effusion concentrations of cefixime during acute otitis media with effusion and otitis media with effusion.
Topics: Acute Disease; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Ear, Middle; Humans; Infant; Otitis Media with Effusion | 1997 |
The sensitivity of Escherichia coli O157 to some antimicrobials by conventional and conductance assays.
Topics: Cefixime; Cefotaxime; Escherichia coli O157; Microbial Sensitivity Tests; Tellurium | 1997 |
Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Culture Media; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Osmolar Concentration; Penicillins | 1997 |
In vitro activity of cefixime versus ceftizoxime against Salmonella typhi.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Salmonella typhi; Typhoid Fever | 1997 |
A case of pseudolymphoma leukaemia syndrome following cefixime.
Topics: Cefixime; Cefotaxime; Cephalosporins; Diagnosis, Differential; Female; Humans; Leukemia; Middle Aged; Pseudolymphoma; Sezary Syndrome | 1998 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
In vitro activity and clinical evaluation of cefixime in urinary tract infection.
Topics: Adult; Aged; Cefixime; Cefotaxime; Cephalosporins; Drug Administration Schedule; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections | 1998 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 19-1998. A 70-year-old man with diarrhea, polyarthritis, and a history of Reiter's syndrome.
Topics: Aged; Arthritis; Arthritis, Reactive; Cefixime; Cefotaxime; Cephalosporins; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male | 1998 |
Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Respiratory System; Streptococcus pneumoniae | 1998 |
Detection of hemolysin variants of Shiga toxin-producing Escherichia coli by PCR and culture on vancomycin-cefixime-cefsulodin blood agar.
Topics: Bacterial Toxins; Base Sequence; Blood; Cefixime; Cefotaxime; Cefsulodin; Culture Media; Escherichia coli; Feces; Food Microbiology; Hemolysin Proteins; Humans; Molecular Sequence Data; Sequence Alignment; Shiga Toxins; Vancomycin | 1998 |
Bacterial orchitis in a baby with imperforate anus.
Topics: Anus, Imperforate; Cefixime; Cefotaxime; Cephalosporins; Escherichia coli Infections; Humans; Infant; Male; Orchitis; Recurrence; Ultrasonography, Doppler, Color | 1998 |
Overview of the clinical features of cefixime.
Topics: Bacterial Infections; Cefixime; Cefotaxime; Cephalosporins; Chemistry, Pharmaceutical; Drug Administration Schedule; Humans | 1998 |
Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection.
Topics: Amoxicillin; Animals; Cefixime; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Humans; Mice; Penicillin Resistance; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 1998 |
Cefixime in the treatment of upper respiratory tract infections and otitis media.
Topics: Cefixime; Cefotaxime; Cephalosporins; Humans; Otitis Media; Patient Compliance; Penicillin Resistance; Respiratory Tract Infections; Streptococcal Infections; Treatment Outcome | 1998 |
Cefixime for switch therapy.
Topics: Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Cost-Benefit Analysis; Drug Administration Schedule; Humans; Infusions, Intravenous; Practice Guidelines as Topic; Treatment Outcome | 1998 |
Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Humans; Penicillins; Spain; Urinary Tract Infections | 1998 |
Clinical role of cefixime in community-acquired infections.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Cephalosporins; Drug Administration Schedule; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Infusions, Intravenous; Treatment Outcome | 1998 |
Absence of a post-antibiotic effect (PAE) of beta-lactams against Helicobacter pylori NCTC 11637.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Cefixime; Cefotaxime; Cephalosporins; Colony Count, Microbial; Culture Media; Helicobacter pylori; Microbial Sensitivity Tests; Penicillins | 1998 |
HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms.
Topics: Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Dosage Forms; Reproducibility of Results; Sensitivity and Specificity | 1998 |
Radiation induced effects on cephalosporins: an ESR study.
Topics: Cefixime; Cefotaxime; Cefpodoxime; Cefsulodin; Ceftizoxime; Cephalosporins; Electron Spin Resonance Spectroscopy; Free Radicals; Gamma Rays | 1999 |
Antibiotic therapy for Salmonella enteritis.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Child; Child, Preschool; Enteritis; Humans; Infant; Salmonella Infections | 1999 |
Selective type-1 hypersensitivity to cefixime.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Drug Hypersensitivity; Female; Humans; Urticaria | 1999 |
Association of IgA nephropathy with Clostridium difficile colitis.
Topics: Acute Kidney Injury; Adult; Cefixime; Cefotaxime; Cephalosporins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Glomerulonephritis, IGA; Humans; Kidney | 1999 |
Oral or IV antibiotics for the treatment of febrile children with UTIs?
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Fever; Humans; Infant; Infusions, Intravenous; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Tract Infections | 1999 |
Cefixime versus cefotaxime against gram-negative bacteria causing urinary tract infections.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 1989 |
Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.
Topics: Amino Acid Substitution; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Cephalosporin Resistance; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Haemophilus influenzae; Histidine; Humans; Lysine; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Sequence Analysis, DNA; Spain | 2007 |
Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Topics: Anti-Bacterial Agents; Asia, Southeastern; Australia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Dose-Response Relationship, Drug; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pacific Islands; Treatment Failure; World Health Organization | 2009 |
Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: application to validation and quantification of cefepime, cefixime and cefoperazone.
Topics: Amniotic Fluid; Calibration; Cefepime; Cefixime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Molecular Structure; Pregnancy; Reproducibility of Results; Temperature | 2009 |
Coincident diagnosis of a pulmonary abscess and ascaris lumbricoides infection: a possible causal connection?
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antinematodal Agents; Ascariasis; Ascaris lumbricoides; Cefixime; Cefotaxime; Child; Comorbidity; Drug Therapy, Combination; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Abscess; Male; Mebendazole; Tobramycin; Tomography, X-Ray Computed | 2012 |
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Female; Genetic Heterogeneity; Humans; Infant, Newborn; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Phylogeny; Sequence Analysis, DNA; Streptococcus agalactiae | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Transfer of plasmid-mediated CTX-M-9 from Salmonella enterica serotype Virchow to Enterobacteriaceae in human flora-associated rats treated with cefixime.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Chromatography, High Pressure Liquid; Conjugation, Genetic; Culture Media; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Feces; Female; Humans; Intestines; Male; Mass Spectrometry; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Plasmids; Rats; Salmonella enterica | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.
Topics: Animals; beta-Lactamases; Cefaclor; Conjugation, Genetic; Drug Resistance, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Molecular Epidemiology; Molecular Sequence Data; Pasteurella multocida; Plasmids; Replicon; Spain; Species Specificity; Transformation, Genetic | 2010 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |